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ABSTRACT
SEMI-PARAMETRIC METHODS FOR PERSONALIZED TREATMENT
SELECTION AND MULTISTATE MODELS
Chathura Siriwardhana
April 14th 2016
This dissertation contains three research projects on personalized medicine
and a project on multi-state modelling.
The idea behind personalized medicine is selecting the best treatment that
maximizes interested clinical outcomes of an individual based on his or her genetic
and genomic information. We propose a method for treatment assignment based on
individual covariate information for a patient. Our method covers more than two
treatments and it can be applied with a broad set of models and it has very desir-
able large sample properties. An empirical study using simulations and a real data
analysis show the applicability of the proposed procedure.We then extend this idea
for treatment section for survival outcomes under right-censoring by introducing
re-weighted estimation to adjust the bias caused by censoring. Series of empirical
studies using simulations show the desirable performance of re-weighted estimation
concept in treatment selection in finite sample cases. We provide a real data ap-
plication of the proposed procedure to illustrate the applicability for right-censored
data. Next we propose a novel method for individualized treatment selection when
the treatment response is multivariate. The proposed method uses a rank aggre-
gation technique to estimate an ordering of treatments based on ranked lists of
treatment performance measures such as smooth conditional means and conditional
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probability of a response for one treatment dominating others. An empirical study
demonstrates very desirable performances of the proposed method in finite sample
cases. We also present a data analysis using a HIV clinical trial data to show the
applicability of the proposed procedure for real data.
Multi-state models are extensions of simple survival models that incorporate
the progression of a subject in an interconnected system such as a disease net-
work. An important measure arising from a mutistate model is the subjects’ state
occupational probabilities given baseline covariates. In the final portion of this dis-
sertation we introduce an inverse censoring probability re-weighted semi-parametric
single index model based approach to estimate conditional state occupation prob-
abilities of a given individual in an acyclic multistate model under right-censoring.
Besides obtaining a temporal regression function, we also test the potentially time
varying effect of a baseline covariate on future state occupations. We show that
the proposed technique has desirable finite sample performances. Its performance
is competitive when compared with two other existing approaches. We illustrate
the proposed methodology using two different data sets. First we re-examine a
well known data set on various event times tracking the progression of a sample of
leukemia patients undergoing bone marrow transplant. Our second illustration is
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This section introduces three projects focused on different aspects in person-
alized medicine. In particular we address the following topics.
• Personalized plans with multiple treatments
• Personalized treatment selection for survival outcome
• Personalized treatment plans with multivariate outcome measures
We provide introductory outlines of these projects as below.
1.1.1 Personalized plans with multiple treatments
Designing optimal treatment regimes based on individual patient character-
istics has gained a momentum over the last few years (see for example van’t Veer
and Bernards, 2008; Varquez, 2013). Dynamic treatment regimes that are geared
towards the “best” outcome for a patient based on his/her genetic and genomic
markers are of high importance. Rather limited literature on this topic mainly
deals with deciding between two treatments based on patient characteristics. As-
suming without any loss of generality that a larger outcome is desirable, the methods
developed in the literature essentially determine the larger conditional expectation
1
of the outcome given the set of markers for the patient. Cai et al. (2011) use
a smoothed sub-group mean in the comparison of two treatments. Here the sub-
groups are determined via a set of contours (scores) that define overall similarities
among patients. For continuous responses, these scores have been defined via linear
models. Qian and Murphy (2011) discuss a two step procedure that is based on
an estimation of a conditional mean followed by a maximization of that mean over
a set of possible treatments. In a different approach for treatment assignments,
Zhao et al. (2012) consider an optimization technique to select between two treat-
ments where the binary optimization procedure is within a class of pre-specified
model functions. Drawing parallels to the support vector machine technology, these
authors show decision optimality of the treatment selection procedure within the
binary framework showing that the procedure discussed in Qian and Murphy (2011)
is inferior to theirs in the two treatments case. In a more recent article, Zhang et al.
(2012) use a robust conditional mean estimation method to alleviate possible wrong
model postulation when one estimates the conditional mean for each patient’s pro-
file. Schulte et al. (2014) provide details of using Quality learning (Q-learning) and
Advantage learning (A-learning) concepts in devising sequential rules based on a set
of pre-specified decision points. The optimality of the decision algorithm, based on
the conditional sequential mean, has been discussed by these authors. While math-
ematically and computationally tedious, it gives a sequential decision rule that self
updates the changing patient behavior in switching to a different treatment. Ad-
ditional references on dynamic treatment regimes can be found in Schulte et al.
(2014). Treatment selection based on observational studies has been treated by
many authors. Readers are referred to Robins et al. (2004, 2008) and references
therein for additional details of such procedures.
In many treatment selection situations clinicians have more than two treat-
ments to select from and the decision of assigning the treatment protocol based on
2
individual patient characteristics is highly desirable. In this work, we discuss the K
treatment (K ≥ 2) scenario where we compare quantities that are suitable approxi-
mations to true conditional probabilities of outcome variable of each treatment dom-
inating other treatments given patient specific scores constructed from covariates.
In particular, instead of estimated marginal conditional expectations, we examine
estimated conditional probability of each treatment dominating the others based
on K independent pairs of outcomes and covariates, one for each treatment. We
choose the optimal treatment as the one that has the highest estimated probability
of dominating every one else for a given patient score. This allows one to compare
treatments for a wide variety of distributions of outcome measures. As seen in our
empirical investigations, the performance of this method is comparable to selection
using conditional means when responses have finite means. In our approach, scores
are defined via a set of Single Index Models (SIMs) or Partially Linear Single Index
Models (PLSIMs) and our scoring system simplifies to the same type of scoring as
in Cai et al. (2011) if K = 2. The method we propose is general where the above
SIMs (PLSIMs) used to obtain scores can be quantile regression models rather than
mean regression models, thus allowing a broad class of structures to get a suitable
score. Empirical evaluations of this new mechanism using a detailed simulation
study to assess the accuracy of treatment selection show that the proposed method
is comparable with existing methodology in the two treatment option with linear
models, it has a higher accuracy in the two treatment case with SIMs and performs
very well in the multiple treatment case. Furthermore, we applied our method to an
existing dataset with multiple treatment arms to examine the use of treatment as-
signment based on patient characteristics. The results show that one arm is highly
preferred over the others for patients in this study with respect to the primary out-
come variable which was a blood count. We also assessed possible gains or losses of
patient survival had the patients were assigned according to the rule proposed here.
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Interestingly our study reveals that there could have been an advantage in terms of
survival also to have used our selection method in the treatment assignment.
1.1.2 Personalized treatment selection for survival outcome
In many severe illnesses, for examples in cancer or HIV, a patients’ survival
time is usually considered as the primary clinical outcome when one is investigating
different treatment options/protocols. When the clinical response of interest is a sur-
vival outcome, patient survival times are often subject to censoring due to dropouts,
competing risks or administrative reasons forcing treatment selection methods de-
veloped for complete observations to become inapplicable. Exiting literature on
personalized treatment rules is often limited to completely observed responses. In
this part of our research we develop a treatment selection method that addresses
the multiple treatments selection issue with right-censored survival outcome.
Frequently, censoring adds an additional complexity to any statistical prob-
lem. It becomes more complicated when the censoring mechanism is a non-random
process. Variety of methods have been developed to address this issue. Often, in
regression methodology, the bias caused by partially observed observations is han-
dled by utilizing a weighting scheme; specifically the inverse censoring probability
weighting (ICPW), a widely applied technique in such problems.
This idea was first developed by Koul et. al (1981) for survival outcomes in
regression. Subsequently this idea has been widely applied in many survival related
studies. Robins and Rotinizky (1992), and Robins (1993) discussed a new class of
tests and estimators for Cox model, accelerated failure time models and a model
for the mean treatment effect, in case of dependent censoring, using a re-weighted
scheme. Satten and Datta (2001) derived Kaplan-Meier estimator as an IPCW av-
erage. Satten et al. (2001) implemented this idea to estimate the marginal survival
4
function in the presence of time dependent covariates, calculating covariate depen-
dent censoring probabilities using Aalens additive hazard model (Aalen, 1980, 1989).
Datta and Satten (2002) estimated integrated transition hazards and stage occu-
pation probabilities for non-Markov systems under dependent censoring utilizing
IPC weights calculated using Aalen’s linear model. Similar to these studies, in this
work, we use a weighting scheme in all estimation steps of personalized treatment
selection methods proposed above when responses are censored. This involves two
steps: first estimating treatment specific SIM models to calculate patients’ scores
followed by estimating the probability of one treatment dominating all others for a
given score. Lopez et al. (2013) discussed adjusting the single index estimator in the
case of right censored observations using Cox model based weights for covariate de-
pendent censoring. Our proposed re-weighted single index estimator is an extension
of Ichimura et al. (1993) single index estimator, weighted by IPCW obtained by
Aalens additive hazard model under covariate dependent censoring. In the case of
random censoring, a Kaplan-Meier estimator based weighting scheme can be used.
In the same fashion a new re-weighted estimator is proposed to estimate the treat-
ment selection probability. We evaluate the re-weighted single index estimator and
the proposed treatment selection concept via an extensive empirical study. We
compare our method with an alternative method based on Cox’s (1972) approach.
To demonstrate practical applications, we apply this method to a real dataset with
multiple treatments, where the survival outcome is heavily right-censored.
1.1.3 Personalized treatment plans with multivariate outcome measures
Current methods in personalized medicine only deals with deciding between
treatments based on a single outcome measure modeled against patient character-
istics. Assuming without any loss of generality that a larger outcome is better, the
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methods developed in the literature essentially determine the best treatment as the
one associated with the largest of a measure of dominance. Existing literature use
either a conditional location parameter (Cai et al., 2011; Qian and Murphy, 2011;
Zhao et al. 2012; Zhang et al. 2012; Zhao et al., 2015) or a measure based on a
conditional probability of an outcome for one treatment exceeding the outcomes for
others, given the set of markers for the patient, which described in the first project.
In many practical situations the success of a treatment cannot necessarily
be measured via a single outcome as a variety of factors may compel both patients
and clinicians to consider recovery in a rather broad view. For example, in deciding
a treatment for a cancer, a clinician may use multiple values of gene expressions
from different families of genes (Kelly et al., 2011,) as endpoint indicators of a
successful treatment. Situations where the disease is not curable, eg: Multiple
Myeloma, may require monitoring multiple measurements such as immunoglobulins,
creatinine level etc. as outcome measures in planning optimal long term treatment
regimes. Also, in many cancer treatment regimes while longer remission times are
highly desired, the impact of drug side effects/reactions, long term effects from drug
combinations, the quality of life, social, family and economic factors etc. can also
play an important role in deciding on treatment protocols. Hence, selecting the
best treatment considering multiple outcome measures becomes a relevant issue for
most patient populations.
In this work we consider selection of the optimal treatment among K possible
treatments for a patient using his or her baseline characteristics when multivariate
outcomes (responses) are to be considered. First, to handle statistical issues aris-
ing due to high dimensional covariates, each patient is assigned a score based on
his/her covariate values. Then we use a weighted rank aggregation method (see
for example Pihur et al., 2007 and Pihur et al., 2009) to combine ranks (orderings)
assigned to treatments based on each response. These ranks can be determined for
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each response using an existing criteria such as ordered conditional mean for each
response given the patient score (eg: Zhang et al. 2012) or quantities based on
conditional probability of one treatment dominating others given the patient score,
as described in projects 1 and 2. Additionally, the rank aggregation method in
Pihur et al. (2007) is flexible to assign different importance factors to each response
variable. This allows one to use apriori opinions on the importance of each response
in determining the best treatment procedure. Our simulations studies show that
the proposed method has very desirable properties in terms of selection frequency
of the best treatment. A real data analysis show differences in the selection of the
best treatment using multi responses compared with the selection using a single
response.
1.2 Multistate models
In this section we introduce a project on estimating conditional state occu-
pation probabilities of an individual given covariates under right-censored data in
a disease network.
1.2.1 Flexible semi-parametric regression of state occupational probabilities in a
multistate model with right-censored data
Multi-state models represent subjects’ movement along time in terms of state
occupation starting from an initial state to a final (absorbing) state. It can be a sim-
ple survival model that describes transition between two states or a more complex
model which contains several intermediate and final states. The well studied bone
marrow transplant data described by Copelan et al. (1991) is an example of such
a system, which illustrates the transition of acute leukemia subjects in numerous
different clinical states in time, after the bone marrow transplant. An important in-
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vestigation for such a system centers around future state occupancy of an individual
at a specific time since enrollment into the system given subject specific informa-
tion. In reality, the complete movement of a subject in a multistate model may
not fully be observable due to censoring, which restricts of using typical regression
concepts for this problem. In this work, we propose a new method to estimate the
conditional state occupation probability given a subject’s covariates, in the presence
of right-censoring. In our model, transitions between states are allowed to follow
a dynamically varying nonlinear relationship with the individuals’ covariates. Fur-
thermore, the functional form of this non-linear relationship is semi-parametrically
estimated at every time point using two single index models and thereby offering
great flexibility in practice.
The literature of multistate models has been fairly dominated by paramet-
ric approaches over a long period. See Anderson and Keing (2002) for examples.
However several works based on fully nonparametric concepts have added a great
momentum to this area. In the past, Aalen (1976, 1978) and Aalen Johanson (1978)
introduced nonparametric estimators of state occupational probabilities of a mul-
tistate model based on Nelson-Aalen type transition hazards. Datta and Satten
(2001, 2002) showed the validity of these estimators under non-Markovian setting
and extended their work further for subject dependent censoring. Introducing a new
avenue to the parametric approach in multistate models, Anderson and Klein (2007)
introduced a pseudo-values based regression approach starting with a marginal es-
timator which could be both parametric or nonparametric. Mostajabai and Datta
(2013) developed a fully nonparametric approach to estimate conditional ‘state-to-
state transitions counts’ and ‘number at-risk’ processes of a progressive multistate
model under right-censoring given a value of a covariate. They incorporated the
inverse probability censoring weighting (IPCW) concept described in Datta and
Satten (2002), Satten and Datta (2002) to adjust the selection bias caused by the
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censoring mechanism. However, limiting the practicability, their method handles
only a single contentious covariate. Recently Chakrabory, Datta, and Datta (2015)
extended this approach to multiple covariate cases, using the generalized additive
model (Hastie and Tibshirani, 1990). However, this approach considers binary
outcomes as contentious values between [0,1] interval for the model estimation,
which may cause instability in the estimation. Furthermore, the robustness of their
method under departure from the pre-assumed additive structure is uncertain. We
propose a novel method to estimate underlining temporal processes of a multistate
model, conditionally on given a covariate vector, introducing IPCW re-weighted
binary choice Single Index Model (SIM). This approach allows one to estimate the
conditional transition matrix for a given covariate vector at a specific time point,
even when the transition mechanism has a highly nonlinear and rapidly varying de-
pendency with multivariate baseline covariates. This is followed by a product limit
calculation as in Datta and Satten (2002) to produce estimated conditional state
occupying probabilities given the baseline covariates. Series of simulation studies
show that the proposed method has desirable finite sample properties and it is ro-
bust under departure SIM from. We show that our method is fairly competitive
for both estimation of the regression function and testing the effect of a baseline
covariate, for future state occupation at a given time, by numerical comparisons
with existing methods suitable for each of these purposes. We demonstrate the
applicability of the proposed methodology in real life using two data sets resulting
bone marrow transplantation and spinal cord injury studies.
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CHAPTER 2
PERSONALIZED PLANS WITH MULTIPLE TREATMENTS
2.1 Treatment Selection
In this section we describe the proposed procedure and list some of its de-
sirable large sample properties. Let (Y ∗i ,X) be the hypothetical (counterfactual)
response and covariate pair for treatment i, i = 1, . . . , K where larger values of
the response are indicative of better outcomes and X is a vector of r covariates.
Assume further that a patient’s covariate value X is used to obtain a lower dimen-
sional composite patient score U(X). In practice one cannot observe the whole
vector (Y ∗1 , ..., Y
∗
K)
′ for a single patient. However, using iid observations of type
(Y˜i,Xi, Ai), i = 1, ..., n where Ai is the binary treatment indicator for two treat-
ments and Y˜i is the observed response for the ith patient, previous authors have
proposed the estimated difference in conditional means given a score U to com-
pare two treatments. For example, Zhang et al. (2012) use robust estimators of
E[Y ∗1 |A = 0, U(X)] − E[Y ∗2 |A = 1, U(X)] where U(X) = X and A = 0, 1 assign
treatments 1 and 2 respectively.
In our approach, we consider pairs of independent observations (Yk,Xk) from
the marginal distribution of (Y ∗k ,X), k = 1, ..., K to extend the treatment selection
for K treatments using a set of probabilities defined as
pi(u) = P [Yi > maxi 6=jYj|U(Xk) = u; k = 1, ..., K]; i = 1, ..., K (2.1)
for a suitable score defined via a score function U . Note that in (2.1), the Y s do
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not denote the set of true counterfactuals for a patient (given the set of X) but are
independently distributed with the same marginal distributions (given the set ofX).
Although the function pi(u) does not use the joint distribution of (Y
∗
1 , ..., Y
∗
K ,X)
for a patient with covariate value X, we argue that pi above nevertheless gives
a measure of dominance for the ith treatment over the others and hence can be
used in selecting the best treatment. This is an alternative to measures based on
conditional expectations which require restrictive moment assumptions on the error
distribution for all inference aspects in a regression context, the natural framework
of handling such data. On the other hand, estimation of quantities like pis can be
done using conditional U-statistics with minimal assumptions. In our approach,
for a given set of functions p1(.), ..., pK(.), we define the best treatment for patients
with a score U0 as the treatment given by
k∗(U0) = arg max
1≤i≤K
{pi(U0)}. (2.2)
This procedure can be thought of as maximizing a value function that is the joint
conditional expectation of an indicator of one treatment dominating the others given
the score rather than evaluating E[Y |U ] for each treatment and picking the largest.
For example, in Zhao et al. (2012), the best treatment was in principle defined
as the index corresponding to the larger of E[Y1|U ] and E[Y2|U ] where Y1 and Y2
are the responses for each treatment. In practice, we propose to use estimators of
pi(U0) based on clinical data and then choose the best treatment as the one that is
given by the corresponding estimator of k∗(U0).
The above approach can be meaningfully used for any set of models that is
appropriate for relating responses and covariates provided that those models define
an ordering of the above pis for at least one score so that one of the treatments
stands out. If several treatments have the same largest pi value for a given score,
one may pick one of those at random. As shown below, one set of models that can
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provide such an ordering are Single Index Models (SIMs). In the sequel we base our
discussions on Single Index Models relating response Yi for the ith treatment and
covariates Xi via
Yi = gi (β
′
iXi) + i (2.3)
for i = 1, . . . , K where each βi is a r-vector of parameters, gis are unknown link
functions for which we assume some reasonable smoothness conditions to hold, and
 is an error term with E[|X] = 0. This model can also be taken as a quantile
regression model with suitable modifications.
In methods based on conditional means, one would ideally use E[Yi|X] to
select the best treatment. However, when X has very high dimension, a natural
choice is to use a composite score U(X) that has a much smaller dimension. We






for all i 6= j, then the corresponding
pi(u) > pj(u), i 6= j for the realization U = u for our proposed score. Hence, using
pis to choose the best treatment is somewhat more general than using conditional
expectations. Although the properties of the proposed approach discussed in the
sequel are for mean SIMs, they all also hold for quantile SIMs models. Additionally,
those properties extend to PLSIMs as the parameters of the linear part of PLSIMs
can be estimated at a
√
n rate (see for example Liang et al., 2010).
If the model relating Yi to Xi is not a SIM, we can still implement the
same mechanism of obtaining the scores via a single index model approximation
to the mean or the median of the responses and then estimate the corresponding
pis. This can be thought of as using a first order Projection Pursuit Regression
to model the responses. Since nonparametric estimation of pis require minimal
model assumptions, our approach is applicable for a very wide class of models. For
notational simplicity, we only list properties of the procedure for conditions that
are appropriate for mean SIMs . Modifications in these conditions needed for other
models are minimal.
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Our data are of the following form. Let Yij indicate the jth responses from
a group of ni individuals under treatment i with covariate values Xij, j = 1, . . . , ni.
The sample sizes ni are assumed to satisfy the condition that ni/N tends to a
positive number where N =
∑




iXij) + ij, j = 1, . . . , ni. (2.4)
Our approach to define an appropriate overall score U is first to use a rea-
sonable model to obtain a treatment specific score for each patient. The score for
treatment i measures how favorable it is for a patient to receive this treatment when
compared to if he or she were to receive other treatments. To be more specific, we
first define










Next, we define the overall score to be the combination of the maximum of these
treatment specific scores, and an index that indicates for which treatment the max-
imum has been achieved for the particular covariate value. That is, we define
S (X) = max
i
{Si}
δ (X) = arg max
i
{Si} . (2.5)
Then, for a patient with covariate value X we define the patient score as U(X) =
(S(X), δ(X))′. Note that the score U(X) reduces to the score used in the two
treatment case by Cai et al. (2011) if we restrict gs to be linear. Also, if K = 2 and
errors are symmetric about 0, δ becomes the index for the treatment with the larger
location parameter for a given X. However, when K > 2, this is not necessarily
the case.
In practice one does not know the error distributions and model functions
for models defined in 2.3 and therefore we cannot directly calculate pis at a given
score u. Thus, to apply the proposed selection method, we first need to estimate
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each pi using a standard function estimation method. This requires observed Yij
values as well as observed U values corresponding to those responses. However, Us
defined above are hypothetical scores for a covariate value X as we do not know
gis and βis. Hence, in estimating pis, we propose to use “estimated” U(Xij) values
, Uˆ(Xij), say, corresponding to responses Yij, j = 1, ..., ni; i = 1, ..., K.
Now, to obtain Uˆ(Xij) values, suitable estimators of link functions gis and
index vectors βis can be used to construct estimators Sˆ (X) and δˆ(X) of S(X) and
δ(X), respectively. There is a vast literature on estimating the link function and
the index vector of a single index model (see, for example, Hristache et al., 2001, Yu
and Ruppert, 2002 and references therein) allowing us to use one out of a several
available reasonable estimation methods to estimate the gs and the βs. We used
the procedure given in Hristache et al. (2001) in our simulations and data analysis
in the sequel. In the sequel these estimators will be generically denoted by gˆi and





















Uˆ(x) = (Sˆ (x) , δˆ (x))′ (2.6)
We randomly select an index δˆ in the unlikely event that multiple treatments
produce the same Sˆ. Now, we construct our estimator for pi(u), i = 1, ..., K at a
given u = (s, d)′ as follows. Define
J = {(j1, . . . , jK) |ji ∈ {1, . . . , ni}, i = 1, . . . , K} .
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where w is a kernel function with w ≥ 0 and ∫ w(t)dt = 1, and his are a set of






















δˆ (Xkjk) = d
)
.
Now, taking an approach similar to the construction of conditional U -statistics
(Stute, 1991), an estimator of pi(u), i = 1, ..., K can be defined as
pˆi (u) =
∑
J∈J I [Yiji > maxk 6=i {Ykjk}] wˆJ (s) ηˆJ (d)∑
wˆJ (s) ηˆJ (d)
. (2.7)
For a realization X0 of the covariate X, if we knew the corresponding realization of
the score, u0 = (S(x0), δ(x0))
′, we can estimate pi(u0) by pˆi(u0). However, due to
the aforementioned reasons, we can only find an estimate uˆ0 of u0 using 2.6 above.
Thus, we use pˆi(uˆ0) as our estimate of pi(u0) for i = 1, ..., K. Finally, the estimated
best treatment for a patient with estimated score uˆ0 is defined as
kˆ∗ = arg max
1≤i≤K
{pˆi(uˆ0)}. (2.8)
Under reasonable conditions stated below, we can show that
pˆi(uˆ0)→ pi(u0) (2.9)
in probability for each i. Hence, if for some k∗, pk∗(u0) > maxj 6=k∗{pj(u0)}, then the
treatment selection procedure described above is consistent since the best treatment
is defined as the treatment corresponding to the largest pi and, given the property
pˆi(uˆ0)→ pi(u0), our procedure selects the best treatment with probability tending
to one. The ordering of the pis depends on models that relate the responses and
the covariates.
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Bandwidth selection for estimating the link functions and pis is a challenging
issue. Method suggested in Wand and Jones (1995) seemed to perform reasonably
well in our simulations and data analysis. However, these choices may not be
optimal. We do not investigate the optimal bandwidth selection issue in this work.
2.1.1 Theoretical Properties
In this section we list a few results that show the consistency of the pro-
posed procedure. We begin by introducing some conditions that are needed to
develop these theoretical results. In the sequel we assume that the random vari-
ables (Yi,Xi), i = 1, ..., K are independent and further assume that Xi, i = 1, ..., K
are iid. Let F (s, d) be the common joint distribution function of (S (X1) , δ (X1)).
We define Ti = gi (β
′
iX1), T = (T1, . . . , TK)
′ and we let fT (t) be the joint pdf of T.
We need following additional assumptions.
Assumption 1. F (s, d) is absolutely continuous in s for fixed d and has a density
function f (s, d), which is bounded.
Assumption 2. The kernel function w is symmetric, has bounded support, Riemann-
integrable, nonnegative, bounded away from zero at 0, and has bounded derivative
and finite total variation.
Assumption 3. fT is continuous.
Assumption 4. The errors ij, j = 1, ..., ni; i = 1, ..., K are i.i.d with a continuous
pdf f (ε) and f (0) > 0.
Remark 1. All distributional assumptions above are very reasonable and easily
satisfied for many error distributions. Assumptions regarding the kernel function w
are standard in nonparametric smoothing literature.
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The following lemma shows that the orderings of the pis exist under models
specified in 2.3. The proofs of some of these results use techniques similar to those
used in the proofs of generalized U -statistics theory (Stute, 1991). However,since
the generalized U -statistics theory is not directly applicable here, we give outlines
of the proofs in the Appendix.
Lemma 1. Under Assumption 1-4 and models 2.3, for a realization u = (s, d)′ of
the score U(X) defined above, functions pi (u) , i = 1, ..., K are continuous in s and
pd (u) > max1≤k≤K;k 6=d pk (u).
The above lemma shows that under the SIM structure, if there is a link
function function dominating others at a given covariate value, then there is a
corresponding p function that dominates the other p functions over a non trivial set
of scores. We now illustrate the consistency of pˆi (uˆ0) as an estimator for pi (u0) at
a given score u0.
For our next result which shows that the estimator pˆ (uˆ0) converges to pi(u0)
we need the following assumption. In light of Remark 2 in the Appendix where the
proof of Lemma 2 is provided and uniform convergence properties of nonparametric
estimators of the link function in Single Index Models (see Wang and Yang (2007)
and references therein), we see that this is a reasonable assumption.
Assumption 5. For each i = 1, . . . , K, smoothing parameters hi ∝ N−1/5 and
supx∈SX
∣∣∣gˆi (βˆ′ix)− g (βix)∣∣∣ = Op (N−2/5 logN).
Now we have the following.
Theorem 1. Under Assumptions 1-5, for u0 and uˆ0 defined above, we have pˆi (uˆ0)−
pi (u0) = op (1) for i = 1, ..., K.
This result shows that the selection of the appropriate treatment is consistent
where we define consistency as being able to identify the index associated with the
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largest p function in 2.1. In the next section we will provide an empirical assessment
of the proposed procedure.
2.2 Empirical Studies
In this section we present a detailed simulation study that investigates the
properties of the proposed procedure in finite samples.
We conducted a series of simulations with the proposed procedure under
various settings. Primarily, we focused on the accuracy of treatment assignment of
a new (test) observation by using estimated values of the pi functions from a set of
training data. This simulation study was performed for both the two and multiple
(K > 2) treatment groups cases. Results for the two groups cases were compared
with the corresponding results for existing methods. However, such comparisons
were not possible with multiple treatments since there is currently no other method
covering more than two treatments. We select our model sets such that each model
in a set dominates other competing models for some combination of covariate values;
in other words, none of considered models fully dominate other models within the
whole covariate space. This signifies, subjects with distinct covariates vectors, could
experience corresponding highest response from different treatments illustrating the
personalized medicine concept.
In our study, we first simulated K independent samples with sample size n
(n = 50 or n = 100) per group. The components of the r dimensional covariate
vectors X were generated independently from a U(−1, 1) distribution, where r
ranged from 3 to 8. Using various link functions and index vectors, where a selected
few are listed in Tables 2.1-2.3, we obtained the treatment responses from model 2.3.
Here the errors were generated from N(0, σ2) and DE(0, σ) where the dispersion
parameter σ was chosen from the set {0.1, 0.2, 0.3, 0.4, 0.5, 1.0}. We have considered
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the performance under both linear and nonlinear regression models. We discuss
additional details of the structures of these models in the sequel.
Once the K samples were generated, we estimated the corresponding SIMs
followed by an estimation of scores at each covariate value. SIMs were estimated
by the procedure given in Hristache et al. (2001) using Epanechnicov kernels (see
Polzehl, 2013). Then, a new covariate value X0 was generated in the same man-
ner as previous covariates above, and for its corresponding estimated score uˆ0, we
calculated pˆi(uˆ0) for i = 1, ..., K. The kernel function in this estimation was taken
to be a U(−1, 1) probability density function (pdf). We chose the bandwidths by
the algorithm given by Wand and Jones (1995) for each i, i = 1, ..., K. We then
generated K new responses, Y ∗i , each with mean gi(β
′
iX0) for i = 1, ..., K, corre-
sponding to this X0 using model 2.3 where the errors were generated independently
from the same error distribution that was used to generate the K original samples.
We define the treatment assignment to be correct if
arg max
i
{pˆi(uˆ0)} = arg max
i
{Y ∗i } .
We repeated this procedure 1000 times for each model and error distribution com-
bination. The frequency of correct treatment assignment for a selected set of cases
are given in the Tables 2.1-2.3 and a few additional tables are provided in the
supplemental materials.
In the analysis of the two groups case (Table 2.1), we used N(0, σ2) errors
with σ = 0.1 and 0.2. We also compared these results with corresponding results
for the two groups assignment methods proposed by Cai et al. (2011), Zhang et
al. (2012), and Zhao et al. (2012). We report the number of cases in which their
selection (using the highest conditional mean) matched with the group with the
largest response. We chose to compare only with these three methods because these
methods highly differ in their approaches and dominate other existing methods in
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the literature for the two groups case. Here, we highlighted the settings in which
other methods underperformed against our method by an asterisk sign. Out of
48 cases the new method competed well with the existing methods in 40 cases.
Clearly, the proposed method has a high accuracy in nonlinear models compared
to the three existing treatment selection methods. In the case of linear treatment
models, which is represented by Model 1 in Table 2.1, the new method performed
comparably to the best method. Model 4 in Table 2.1 was chosen to demonstrate
the robustness of the proposed method, where the requirement of SIM’s is violated.
Even in these cases, the accuracy remained fairly high, showing that the proposed
method is rather robust.
We studied the multiple treatment groups case for K = 3 and 4, using a
variety of models generated from several nonlinear model families. All considered
cases produced results that are generally anticipated in a study of this nature. Cases
involving highly nonlinear curves with minor differences in the mean value function
performed somewhat poor compared with cases where the nonlinearity is less severe
















+ ε, i = 1, ..., K, (Type II).
In each type above, gi is either a sine or a cosine function. In Type I models, the
same single index vector β has been used for the treatment groups where the gi
function varies across the groups. In our simulations we chose this common vector








1×r Table 2.2. In Type II models we used a variety of
βi index vectors whose components were selected in an arbitrary fashion. These
components are given in Table 2.4. For example, in the three treatment case with
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If several models are close to each other within the whole covariate domain, a
high classification error (i.e., incorrect treatment assignment) can be expected due
to the lack of functional separations. In general, the functional behavior of a multi
covariate nonlinear model cannot be easily visualized. Type-I models used here
have relatively substantial functional differences compared to some Type II models
for each K. Tables 2.2 and 2.3 show the correct assignment frequencies for a repre-
sentative set of multi-groups cases. Again, the results for all examined cases were
very similar to the few presented here.
Examination of the results reveal high assignment accuracy for large sample
sizes and low error variability. In general, we observed fairly high accuracies for
low covariate dimensions. The presented simulation results are based on sine and
cosine functions which are bounded in (-1, 1). Hence, an increment in σ by 0.1
adds a relatively large noise to a model. Consequently, as expected, we observed a
decline in the correct assignment frequency as σ is increased. The results for the
three groups case for both Type I and II models are somewhat comparable whereas
the results for Type II models for four groups case were lower compared to those
corresponding to Type I models. As indicated in the previous paragraph, we believe
these differences are due to relative lack of separation in the model functions.
2.3 ACTG-175 HIV Clinical Trial
In this section we illustrate our proposed method using a real clinical trial
dataset.
The data resulted from the ACTG 175 clinical trial (Hammer et al. 1996).
This trial was a randomized, double-blinded, placebo-controlled clinical trial that
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was conducted for comparing antiviral medications for HIV-1 patients whose T-cell
CD4 counts were in the range of 200 to 500 per cubic millimeter. The dataset
(Juraska et al. 2012) contains information on 2136 HIV-1 infected individuals who
were randomized into four treatment arms; those treated with Zidovudine (arm-0),
combination of Zidovudine and Didanosine (arm-1), combination of Zidovudine and
Zalcitabine (arm-2), Didanosine (arm-3). Arms 0, 1, 2, and 3 contain 532, 519, 524,
and 561 patients, respectively. The severity of HIV progression is measured through
a decline in CD4 counts. This trial periodically measured a patient’s CD4 count as
the clinical outcome. In our analysis, we considered the log transformed CD4 count
of a patient after 20 weeks of treatment as the clinical response. As covariates,
we used log-CD4 and log-CD8 counts at baseline, age, weight, and the number of
months a patient received pre-antiviral therapy.
We applied the proposed treatment assignment strategy to the data from all
four arms of the study. We also provide an illustration to compare with several
existing two-treatment methods. In each situation, we randomly selected 200 pa-
tients from each arm as “training” data to estimate the SIMs. Remaining patients
were considered as new (test) patients. After fitting SIMs to training data we
estimated the scores for the test cases and estimated the corresponding pi functions
using Gaussian kernels at corresponding scores to assign each test patient to the
best treatment suggested by the largest estimated pi value.
We report the results for the two group comparisons first. When we used the
proposed method, out of 651 test patients, only 3 were assigned to arm-0, suggesting
that possibly a large number of patients would have experienced a more favorable
outcome from arm-1. We also applied the two-group assignment methods proposed
by Cai et al. (2011), Zhao et al. (2012), and Zhang et al. (2012), for the same
training and test data. These methods also assigned lesser number of patients to
arm 0, than the actual assignment by the randomized trial. We present these results
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in Table 2.5. For example, in Table 2.5, the (1, 0) cell for the Proposed Method
indicates that only 2 out of 319 patients who were actually treated in arm-1 would
have been assigned to arm-0 had we used the proposed method.
In the multiple treatments assignment setting, we have a total of 1336 pa-
tients in the test set. Among them, we assigned the majority: 828 to arm-1 whereas
306 and 186 patients are assigned to arms 2 and 3, respectively. Similar to the two
group assignment, the new method assigns only few patients to arm-0, seemingly
suggesting that one of the other arms almost always dominate arm 0 with respect
to our scoring mechanism. These results are summarized in Table 2.6. We noticed
that, a large number of patients (1023) are proposed to be assigned to a different
treatment arm than their actual assignment. Based on these allocations, it appears
that the majority of patients in the study would have benefited from arm 1.
2.3.1 Examination of the survival aspect
The proposed treatment selection method above is an attempt to assign
patients to receive the optimal outcome based on their score. Given that the above
analysis shows that the optimal assignments based on patient characteristics are
different from actual assignments towards a higher CD4 count, it might be the case
that such an assignment rule could also improve the expected value of the related
survival time conditional on the score. To explore whether such an implication
might hold, we proceed as follows.
In the dataset, there are three types of events: (i) when an individual’s CD4
count drops less than 50% of his/her pretreatment count, (ii) an event indicating
progression to AIDS, (iii) death. Thus, the term “survival time” would denote an
event time in the above sense. In addition, there was right censoring present in the
data. Now, consider the i th subject in the test set with covariate value Xi who is
23
assigned to a particular arm by an assignment mechanism. Suppose the individuals




. Let k∗i be the group the procedure would
assign this patient based on his/her estimated score uˆi and let ki be the treatment
group he was assigned in the original trial. Conditional on uˆ, we estimated the
difference in the survival times in the two groups, as
∆i = E(tk∗i |uˆi)− E(tki |uˆi).




Sˆ(Xi)− h, Sˆ(Xi) + h
}
,
where h was the bandwidth chosen by the procedure given in Wand and Jones (1995)
for scores for all patients. Next, we selected a subgroup of patients from the whole
set (training and test), whose covariate values X satisfy (i) patient was originally
treated in arm k and (ii) Sˆ(X) ∈ Nh and (iii) the score satisfies δˆ(X) = δˆ(Xi). If
the size ( d, say) of the above subgroup is less than 30, we increased the width of
the neighborhood Nh in multiples of h (i.e., 3h, 4h etc.) to make d ≥ 30. After
that the Kaplan Meier estimator was calculated using the survival times of those
individuals in Nh.
Our estimator of the expected survival time for each group, i.e., E(tki|uˆi),
ki = 1, ..., K, was the area covered under the corresponding Kaplan-Meier curve. For
a given uˆi, we then find the estimated survival gain ∆ˆi from the proposed selection
as the difference between the two estimated expectations, Eˆ(tk∗i |uˆi) − Eˆ(tki|uˆi).
Finally we estimate the overall treatment selection efficiency as the averaged ∆ˆis







where N is the number in the test set. Note that a positive value for ρ indicates an
overall effective treatment selection. Table 2.7 gives these ρ values for the proposed
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procedure with two and multiple treatments cases along with the resulting estimated
survival gains for methods proposed by Cai et al. (2011), Zhao et al. (2012), and
Zhang et al. (2012), for the two-groups application. Additionally, we consider the
marginal survival functions and define,
∆
′
i = E(tk∗i )− E(tki),
where E(tk∗i ) and E(tki) are corresponding marginal expected survival times of new
(k∗i ) and actual (ki) arms. Again using the area under the marginal Kaplan Meier
estimates, we calculate estimated values of ∆
′
i, i = 1, ..., N . Similar to 2.10, we
obtain ρm using these marginal estimates. Corresponding ρm’s are also reported
in Table 2.7. Since the proposed treatment selection is based on a scoring scheme,
we argue that examining the score dependent survival outcome would be a more
reliable approach. This is confirmed by the fact ρm ≤ ρ in all cases.
2.4 Discussion
In this Chapter we proposed a novel personalized treatment plan to select
the optimal treatment from a set of multiple treatments. This method is a sin-
gle step procedure which can be easily applied. The proposed method is based on
semi parametric Single Index Models which, add great flexibility in modeling real
life situations. Furthermore, this method can also be used for quantile regression
SIMs providing additional model flexibility compared with existing methods based
on conditional expectations. Our empirical studies show that the proposed method
performs very satisfactorily in selecting the optimal treatment in a multiple treat-
ment setting while outperforming existing methods for the two treatment case for
non-linear models which are more realistic in practical situations. In addition, as
our simulations showed, the method is rather robust against departures from SIMs.
We show that the proposed method has desirable theoretical properties. Our anal-
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ysis of a real clinical trials dataset which has the multiple treatment option reveals
a possible connection between optimal treatment selection and a gain in patient
survival.
This discussion deals with complete responses. However, censoring is very
common in practice. An extension of the proposed methodology to a covariate
dependent censoring setting and various lifetime aspects such as multi state models
is forthcoming. Our study is addressing the optimal treatment selection based on a
single response. However, there are numerous circumstances where the optimality
is desired with respect to multiple criteria. For example, a treatment may have to
be selected to maximize the survival rates but minimize after effects and maximize
the quality of life in terms of temporary side effects. In such cases we have a multi

















(1) (1.5X1 − 0.1X2 + 2X3 + 2X4 − 1.5X5 − 1.6X6)/
√
15.07: Group 1




50 864 889 800* 899
100 891 906 856* 902
0.2
50 794 817 773* 801
100 825 840 821* 844
(2) sin
{













50 900 683* 676* 683*
100 891 722* 698* 728*
0.2
50 860 670* 691* 693*
100 853 708* 683* 718*
(3) sin
{













50 880 605* 633* 678*
100 911 680* 671* 700*
0.2
50 839 606* 603* 672*







+X21 : Group 1
sin
{




+ 0.7X21 : Group 2
0.1
50 920 743* 694* 804*
100 935 794* 764* 842*
0.2
50 908 741* 703* 796*
100 924 774* 740* 834*
Table 2.1: Frequencies of correct treatment assignments in 1000 test cases by four
competing algorithms in the two groups case. The regression models used in the
simulations include linear and nonlinear SIM models, as well as models that are not
SIM. Cases where the proposed method (ours) outperformed a competing method













































50 937 857 733 929 804 649
100 946 866 766 936 846 720
5
50 934 843 761 922 818 682
100 973 916 796 949 843 728
8
50 897 816 707 883 726 563









































50 904 799 653 890 699 529
100 939 822 714 909 773 625
5
50 895 775 640 878 699 518
100 946 827 687 910 752 608
8
50 853 720 549 836 644 438
100 926 809 689 903 717 577
Table 2.2: Frequencies of correct treatment assignments in 1000 test cases by the
proposed method in multiple groups case (K > 2), using Type I nonlinear regression


























































50 956 878 766 924 818 688
100 970 896 796 948 844 737
5
50 930 865 762 926 802 694
100 947 897 802 942 838 741
8
50 888 801 649 862 736 537














































50 830 652 562 772 602 464
100 884 738 616 819 673 513
5
50 727 595 508 731 558 410
100 822 697 557 791 645 508
8
50 725 586 447 685 486 381
100 823 657 549 802 599 490
Table 2.3: Frequencies of correct treatment assignments in 1000 test cases by the
proposed method in multiple groups case (K > 2), using Type II nonlinear regres-







β1 β2 β3 β4 β5 β6 β7 β8
Three
1
3 1.5 1.6 0.9
5 1.5 1.6 0.9 1.2 1.4
8 1.5 1.6 0.9 1.2 1.4 -1.5 1.2 1.6
2
3 1.0 1.4 0.8
5 1.0 1.4 0.8 0.8 0.6
8 1.0 1.4 0.8 0.8 0.6 -1.1 0.8 0.6
3
3 1.3 1.7 0.7
5 1.3 1.7 0.7 0.9 1.1
8 1.3 1.7 0.7 0.9 1.1 -1.3 -0.1 0.9
Four
1
3 0.8 0.6 0.7
5 0.8 0.6 0.7 0.5 0.6
8 0.8 0.6 0.7 0.5 0.6 0.8 0.7 0.5
2
3 1.2 1.4 0.9
5 1.2 1.4 0.9 1.5 0.9
8 1.2 1.4 0.9 1.5 0.9 1.1 1.4 1.2
3
3 0.2 0.3 0.8
5 0.2 0.3 0.8 0.6 0.3
8 0.2 0.3 0.8 0.6 0.3 0.1 0.4 0.6
4
3 1.8 2.1 0.8
5 1.8 2.1 0.8 0.7 0.9
8 1.8 2.1 0.8 0.7 0.9 1.3 1 1.3













Arm-0 Arm-1 Arm-0 Arm-1 Arm-0 Arm-1 Arm-0 Arm-1
Arm-0 1 331 13 319 0 332 28 304
Arm-1 2 317 11 308 0 319 25 294
Total 3 648 24 627 0 651 53 598





Arm-0 Arm-1 Arm-2 Arm-3
Arm-0 2 211 70 49
Arm-1 2 193 77 47
Arm-2 5 201 73 45
Arm-3 5 223 88 45
Total 14 828 308 186
Table 2.6: Four groups treatment assignment summary for ACTG-175 clinical trial,
by the proposed method.









ρ 76.1 73.0 77.2 66.0 56.3
ρm 62.5 58.5 63.1 53.0 32.2




TREATMENT SELECTION FOR SURVIVAL OUTCOME
3.1 Treatment Selection
The goal of this project is to extend project 1 to handle censored responses.
Here, the response is a survival time or an event time that is subject to right
censoring.
Let (Yi, Xi) be the survival response and covariate pair for the i’th treatment
group, the covariate vector is r dimensional. Let Ci denote the right censoring time
and let Ti = Yi ∧ Ci and δ′i = I[Yi ≤ Ci]. We denote the survival function by
S
′
(t) = E{I[Yi > t]}, with hazard function λ(t) and cumulative hazard function
Λ(t). Suppose patients’ covariate is used to obtain a score U(Xi). Assuming all
Yi’s are observed, in our previous work, we define a function pi(u) that provides the
probability of dominance for the i th treatment over others, for a patients’ with a
covariate value Xk and a score U(Xk) = u, for k = 1, ..., K:
pi(u) = P [Yi > maxi 6=jYj|U(Xk) = u; k = 1, ..., K].
For a given set of functions, p1(.), ..., pk(.), for a patient with a score of U0, the
best treatment is given by,
k∗(U0) = arg max1≤i≤K{pi(U0)}.
As we described before, pi(u) is an alternative to measures based on conditional
expectations which requires restrictive moment assumptions. Here, scores are ob-
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tained via a set of single index models or partial linear models define for each group
given by (2.3). We define a patient score as a composite function given by (2.5),
U(X) = (S(X), δ(X)).
Since the score is estimated via a set of estimated single index models, for a given
patient we have an estimated score of Uˆ(X) = (Sˆ(X), δˆ(X))′. For completely
observed responses, the probability of ith treatment dominating the others for a
given score value (u) is given by (2.7). However, once patients’ response’s are subject
to right censoring, some Yij
′s may be unobservable, which makes the application
our of previous treatment selection method directly to available data impossible.
In this study we introduce a modified method developed in parallel to the previous
personalized treatment selection concept. This involves modification of the single
index estimator and the estimator of pi(u). Use of data weighting schemes for
the purpose of bias reduction are well known in statistical literature. One way
to handle censored observations in the context of regression is to introduce a re-
weighing scheme to the original estimator developed for complete data, in a way
that the bias caused due to censoring fades away asymptotically. This idea was
first introduced by Koul (1981), for the randomly right censored data in linear
regression. Datta et al (2001) described estimating the marginal survival time
in the presence of time dependent covariates, using a re-weighted Kaplan-Meier
estimate, applying the IPCW calculated by Aalen’s additive hazard model (1989).
In a recent article, Lopez et al. (2013) described estimating the single index model
incorporating IPCW. In their method, they used cox’s proportional hazard model
to obtain covariate dependent censoring probabilities. Similar to these concepts, in
our study, we introduce a reweighing scheme to estimators of single index model
and p(u) function.
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3.1.1 Estimation of the IPCW Weights
We applied Aalen’s additive hazard model to estimate the weights in the case
of covariate dependent censoring. Aalen’s model is more flexible compared to Cox’s
proportional hazard model. However, it’s important to note that estimating Aalen’s
model involves inverting a non full rank matrix. Although estimated hazards depend
on the solution of the selected generalized inverse, it doesn’t impact the proposed
weighting scheme, since weights are uniquely defined. In this study, we employed
Moore-Penrose generalized inverse. Also, in Aalen’s model there is no strong criteria






where, βj(t) is an unknown function, that needs to be estimated. Zij(t) is a pred-
icable process and Zij(t) is the corresponding value avialabe just before time t.









I(ti ≤ t)(1− δi)A−1(ti)Zi(ti),
where, Zi(t) = (Zi0(t),..., ZiJ(t) ), and A(t) =
∑n
i=1 I(ti ≥ t)Zi(ti)ZTi (ti). Cumula-







In the case of random censoring, we obtain inverse censoring probabilities by Kaplan-
Meier estimator.
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3.1.2 Re-weighted Single Index Estimator
Suppose variable Y is linked to a linear combination of set predictors (X)
represented by β′X via an unknown link function g. SIM model is defined by,
Y = g(β′X) + ,
where,
E(|X) = 0.
For the purpose of identifiability, we may replace β by a unit vector,
θ = β||β||−1.
where ||.|| is the Euclidean norm. Thus, an equivalent model can be written as,
Y = g(θ′X) + .
Assuming all Y ’s are completely observed, Ichimura et al. (1993) proposed an
estimator to estimate the above SIM model. Accordingly, the unknown function
g(.) is estimated at point u, by leave-one-out cross validation method, omitting the
pair of (Yi, Xi),
gˆ−i(u|θ) =
∑
j 6=i Yjωh(u− θ
′
Xj)∑
j 6=i ωh(u− θ′Xj)
.
where, h is a smoothing parameter, ωh(.) = ω(./h), and ω, is a fixed kernel function
with ω ≥ 0 and ∫ ω(t)dt = 1. Ichimura et al. (1993) showed, estimates of θ and h
can be achieved by simultaneously minimizing the following objective function with





Once observed data subject to right censored, above SIM estimator is no longer
valid. We suggest an alternative SIM estimator, which is capable of handling right
censored data in survival outcomes. This new estimator is primarily based on the
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method proposed by Ichimura et al (1993), but it’s re-weighted by a IPCW weighting










j 6=i ωh(u− θ′Xj)
.
Here, Kc(T−) is the survival probability of an individual not being censored just
before time T , which can be estimated from either Aalen’s linear model or Kaplan-
Meier estimator, depending on the censoring mechanism. We estimate θ and h by
minimizing the following weighted objective function denoted by (Sˆ
′
(θ, h)) simul-











For estimators θˆ and hˆ, g(.) function at a new point u0 = θ
′










i ωh(u0 − θˆ′Xj)
. (3.1)
In reality, we replace Kc(.) by its corresponding estimator Kˆc(.). A simulation
study to evaluate the properties of the re-weighted single index estimator showed
reasonable performance under both random and covariate dependent censoring,
seemingly suggesting that the alternative SIM estimator is a reasonable estimator
of estimating patient scores with right censored responses. We explain detailed
results later in the “Empirical Studies”.
3.1.3 Re-weighted Estimator of Treatment Selection
Assuming all treatment responses (Y ) are observed, in project-1 we provided
a treatment selection rule that assigns a patient to the treatment that dominates all
others for a given patient score. The corresponding probability that ith treatment
dominating for a patent with a score of u is given by (2.7). In the same fashion
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as the single index model was re-weighted, we introduce a new estimator of p(u)
capable of coping with right censored data by employing IPCW weighting scheme.
Again, the new rule is structured on the same score criteria given by (2.6). The
new estimator is defined as below. Let
J = {(j1, . . . , jK) |ji ∈ {1, . . . , ni}, i = 1, . . . , K} .











where w is a kernel function with w ≥ 0 and ∫ w(t)dt = 1, and his are a set of






















δˆ (Xkjk) = d
)
.
As indicated before, suppose, Kc(T−) is the survival probability of an individual









Estimator of p(u), is given by,
pˆi (u) =
∑
J∈J I [Tiji > maxk 6=i {Tkjk}] wˆJ (s) ηˆJ (d) κˆJ∑
wˆJ (s) ηˆJ (d)
. (3.2)
For a given patient with a covariate vector x0 and estimated score of uˆ0 = (Sˆ(x0), δˆ0),
the proposed treatment rule assign him/her into k∗ th group if,




As mentioned in the treatment selection for complete data, the optimal bandwidths
selection for this problem is challenging. Our empirical studies demonstrated rea-
sonable performance using the bandwidth selection given by Wand and Jones (1995),
even in the right censored case.
As an alternative approach to the above treatment selection plan that is
based on pi(u)’s, we also propose a method based on comparing conditional expected
means using a re-weighted estimator for smooth means given u = (s, d). The




















δˆ (Xij) = d
) . (3.4)
The optimal treatment using µˆi(u)’s is defined for an individual with an
estimated score uˆ0 = (Sˆ(x0), δˆ0) as,
kˆ∗ = arg max
1≤i≤K
{µˆi(uˆ0)}. (3.5)
In this work we used the Wand and Jones (1995) bandwidth selection concept
for estimating µi(u)’s for a comparative study with optimal treatment selection
based on pi(u)’s.
3.2 Empirical studies
In this section we provide detailed information on a simulation study per-
formed to assess the performance of new treatment selection rule and single index
model estimator for right-censored data.
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3.2.1 Re-weighted Single index estimator
The following simulation study explores the performance of the IPCW re-
weighted single index estimator in finite sample.
In this experiment, we generated survival time Y ’s using a three dimensional
covariate vector X, in a highly non-linear model given by,
Y = a+ sin{pi(β ′X)}+ ε, ε ∼ N(0, 0.12).








. and a = 1.2. Here each component of X was
independently generated from U(−1, 1). The study examines the performance of the
SIM estimator under two censoring mechanisms; random and covariate dependent
with combinations of various censoring percentages ranging approximately from
10% to 50%, and model training sizes (n) from 100 to 2000. Random censoring
time was generated from single parameter scale Exponential distribution with a
parameter φ selected from the set {0.1, 0.3, 0.4}, whereas in the covariate dependent
censoring setting, we obtained censoring time using a function which is a mixture
of two distinct Exponential distributions, defined for a threshold value of a linear
combination of covariates given by,
C ∼ I(β ′cX > w)exp(φ1) + I(β
′
cX ≤ w)exp(φ2).
We fixed w = 0.4 for βc = (0.2, 0.3, 0.4) and selected (φ1, φ2) from the set
{
(0.01, 0.10),
(0.15, 0.40), (0.30, 0.70)
}
. In each scenario, we first estimated the SIM model and
then determined the average L1 distance between predicted and true functions for
a testing set of size 1000, that was generated similarly to the training set. Thus the







Tables 3.1 and 3.2 show average bias, standard error of re-weighted SIM parameters
and average ∆ observed under each setting, using 1000 Mote-Carlo simulations.
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∆ clearly decreased as n increased for both censoring mechanisms and rates,
suggesting that the estimated function asymptotically converges to the true func-
tion. Also, we observed a reduction in bias and standard error for large n. As to




log(∆) ∼ −γ log(n).
In the simulated examples, we observed a linear trend in log(∆avg) vs log(n), sug-
gesting that the above linear relationship is reasonable. These graphs are shown
in Figures 3.1 and 3.2. Estimated γ’s for random censoring with 10%, 30%, 50%
are 0.38, 0.42, 0.43 and for covariate dependent with censoring rates 10%, 30%, 50%
cases are 0.32, 0.31, 0.35 respectively.
3.2.2 Treatment Selection
In this section we provide details of an extensive simulation study that in-
vestigates the properties of the proposed treatment selection method under various
settings. The overall study design is comparable to the empirical study described in
Project 1. Primarily, we focused on the accuracy of treatment assignment of a new
(test) observation by using estimated values of the pi functions from a set of train-
ing data. Illustrating the personalized treatment concept, we choose our model sets
such that each model in a set dominates others for some combination of covariate
values. In this simulation study, we address both two (K = 2) and multiple groups
(K ≥ 2) treatment selection, under random and covariate dependent censoring. We
simulated K,K ∈ {2, 3, 4} independent samples of size n, n ∈ {50, 100, 200} per
group. All components of r dimensional covariate vectors were generated indepen-
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dently from U(0, 1), where r is ranged from 2 to 8. Using various functions and
index vectors, we obtained the survival outcome from model (2.3), where σ was se-
lected from the set {0.1, 0.2}. For the kth, k = 1, .., K group, we generated random
censoring time (Ck) using single parameter Exponential distribution with parame-
ter φk, whereas covariate dependent censoring was obtained using a combination of
two single parameter Exponential distributions, given by following expression.
Ck ∼ I(β ′cX > wk)exp(φk1) + I(β
′
cX ≤ wk)exp(φk2), (3.6)
Here, (φk1, φk2), βc , and wk were chosen specifically for the kth model given by (3.6),
controlling the censoring percentage. We provide all selected censoring parameters
corresponding to each scenario in Tables 3.5 - 3.8. Once K samples were generated,
we estimated SIM for each group using the re-weighted SIM estimator applying
a Gaussian kernel. The probability of not being censored (Kc(.)) was estimated
using Kaplan-Meier and Aalen’s estimators for random and covariate dependent
censoring scenarios, respectively. A new covariate value X0 was generated in the
same manner as generating training set. After that, using the estimated re-weighted
SIM models, scores were calculated at each covariate value including the estimated
score at x0 (uˆ0). We estimated pˆk(uˆ0) and µˆk(uˆ0) for k, k = 1, ..., K, choosing a
U(−1, 1) probability density function as the kernel. The bandwidth was chosen by
Wand and Jones (1995) procedure for each i, i = 1, ..., K. The treatment group
for the new patient was determined via (3.3) and (3.5). Using the treatment mean
model gi(βiX0) we then generated the response Y
∗
i , for each treatment group as
in model (2.3) with the same error distribution used to generate model sets. We
defined the treatment assignment to be correct if,
arg max
i
{pˆi(uˆ0)} = arg max
i
{Y ∗i } .
This procedure was then repeated for 1000 times for each combination of selected
settings. We also considered an alternative approach based on the Cox method,
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where we fit a Cox regression model for the survival outcome of each treatment.
These models are used to find the conditional hazards given individuals’ covariates,
which allows one to estimate the expected survival outcome of a given individual.
In this approach the best treatment can be selected as the treatment with the high-
est expected survival mean. In the case of two groups (Table 3.3), we chose both
linear and nonlinear model functions. When linear models are used, the treatment
selection based on Cox method had the best accuracy in terms of optimal treatment
selection. However, in cases of non-linear model functions, the proposed methods
using pi(u)’s and µi(u)’s clearly compete the Cox approach. In general, we observed
a high selection accuracy for low censoring percentages in both random and covari-
ate dependent censoring settings. Comparing accuracies observed for pi(u)’s and
µi(u)’s, we noticed that use of pi(u)’s has a relatively higher accuracy than µi(u)’s
when the censoring rate gets severe. As to be expected, results revealed compara-
bly high accuracies for large model sizes and low error variances. The model set
4 in Table 3.3 violates the SIM condition. We chose this model to demonstrate
the robustness of the proposed concepts under the departure from SIM structure.
Observed high accuracies reflect the robustness of the proposed concepts against
the departure from SIM assumptions.
We performed simulations for Multiple treatment groups (K = 3, K = 4)
simulations using Type-1 nonlinear models described in “Empirical Studies” of









mension (r) selected from the set of {3, 5, 8} with error standard deviation σ = 0.1
and σ = 0.2. Simulation results that are presented in Table 3.4 for the multiple
group case show high accuracies for larger sample sizes and low censoring rates,
the same trend that was observed in the two groups case. These results indicate
better treatment selection accuracy with pi(u)’s, than µi(u)’s. We observed a rela-
tive decline in the accuracy as the dimension was increased. However, the observed
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result seems to be highly acceptable in consideration of the complexity in treat-
ment selection problem under a high degree of non-linear models and severities of
censoring.
3.3 ACTG-175 HIV Clinical Trial
In this section we illustrate our proposed method using a dataset resulted
from ACTG 175 clinical trial. A complete description of this trial and the data set
is given in Section 2.3.
This trial measured the survival of HIV patients as one of its secondary
outcomes, which had been severally subjected to right-censoring. A primary analysis
of the survival outcome shows the rate of censoring is approximately 80%. In our
analysis, we considered the log transformed number of survived days as the survival
outcome. As covariates, we used log-CD4 counts and log-CD8 counts at baseline,
age, weight, and the number of months a patient received pre-antiviral therapy.
We applied proposed treatment assignment strategies based on two proposed
concepts: probabilities of dominances and smooth means, on the survival outcome
using all four arms of the study. We randomly selected 200 patients from each
arm as “training” data to estimate the SIM’s, while considering the remaining
patients as new (test) patients, which are considered for the treatment selection.
After fitting SIMs to training data we estimated the scores for the test cases and
estimated the corresponding pi(u)’s and µi(u)’s functions using Gaussian kernels at
corresponding scores to assign each test patient to the best treatment suggested by
the corresponding largest estimated pi(u) or µi(u) value.
We present two treatment assignment results in Table 3.9. For example, in
Table 3.9, the (0, 0) cell indicates that 141 out of 322 patients who were actually
treated in arm-0 would have been assigned to arm-0 had we used the proposed
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method based on for probability of dominance. The overall result shows a notable
difference between treatment assignments for proposed techniques. For example,
the major proportion of test patients have been assigned to arm-1, using the proba-
bilities of dominance. On the other hand, the smooth means approach has assigned
a large number of patients to arm-0. Such disparity in treatment selection was
observed throughout our simulation studies also, especially when the censoring rate
was severe. Overall these simulation studies seem to indicate a better performance
in treatment assignment with probabilities of dominances.
In the multiple treatments assignment setting, we have a total of 1336 pa-
tients in the test set. Using probabilities of dominances, we assigned the majority;
553 to arm-2, whereas 42, 254 and 477 patients are assigned to arms 0, 1 and 3,
respectively. This result seemingly suggesting that one of the other arms almost
dominate arm-0 with respect to our scoring mechanism when we use pi(u)’s.These
results are summarized in Table 3.11. Similar to the two treatment assignment we
noticed a clear difference between two methods. A close inspection of the overall
assignment indicates that, a large number of patients; 1105 and 976 are proposed to
be assigned to a different treatment arm than their actual assignment in the original
trial with selectionss based on pi(u)’s and µi(u)’s respectively.
3.4 Discussion
In this work, we developed a novel personalized treatment selection concept
that addresses the multiple treatment selection for survival outcome which can be
subjected to right-censoring. This method is an extension of the project-1 described
in the previous chapter.
We introduced IPCW re-weighting schemes to Ichimura et al. (1993) SIM
estimator and the treatment selection estimator introduced in project-1 to handle
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the selection bias caused by the censoring mechanism. Similar to the method based
on probabilities of dominances, we also introduce a treatment selection concept us-
ing conditional means. Based on an empirical study that evaluate the performance
of the re-weighted SIM estimator, we observed the absolute error associated with
the estimated function goes away asymptotically as sample size increases. The per-
formance of the new treatment selection concept was investigated using a series
of simulation studies to study the of accuracy in selecting the best treatment that
maximizes the patients’ survival outcome. Where we considered both two treatment
and multiple treatments options under various model functions with various rates
of random and covariate dependent censoring. The overall empirical results indi-
cated a reasonable treatment selection accuracy. The proposed method seems to be
robust under the deviation from SIM conditions. Between two proposed techniques;
probabilities of dominances and smooth means, our empirical studies suggested a
comparable performance with both methods under low rates of censoring. However
when the censoring rate is severe, the method based on probability of dominances
is performing relatively better than method based on smooth means. Demonstrat-
ing the applicability of our method in real data, an application of the new concept
using ACTG 175 HIV trial data showed acceptable treatment allocations and its
potential of maximizing the survival outcome.
Since the treatment selection method introduced in project-1 can be utilized
with quantile regression models, for a greater applicability, our method can be
further generalized by adjusting quantile regression SIM estimators using a suitable
re-weighting concept in the same fashion. Often, outcomes of a treatment is not
only restricted to a single response. For example, one may consider patients’ CD4
counts and survival as paired responses for a HIV patient. A possible extension of
our method could be the addressing of such complex treatment selection problems




Censoring Rate Sample Size Bias (10−3) S.E (10−2) ∆(10−1)
β1 β2 β3 β1 β1 β1
100 4.449 -0.875 0.712 9.478 6.975 5.749 2.554
500 -0.226 0.078 0.578 1.574 1.129 2.196 1.217
50% 1000 -0.137 0.074 -0.138 1.151 0.672 1.302 0.944
2000 0.016 -0.018 0.004 1.563 0.536 0.381 0.701
100 -0.209 0.120 0.027 3.679 2.678 4.003 1.836
500 -0.078 0.043 -0.047 1.221 0.713 1.397 0.945
30% 1000 -0.078 0.053 -0.024 0.614 0.394 0.760 0.713
2000 -0.009 0.004 0.001 0.340 0.213 0.478 0.519
100 0.217 -0.274 -1.451 1.887 1.179 2.227 1.152
500 -0.297 0.384 -0.587 0.509 0.317 0.605 0.597
10% 1000 -0.264 0.149 0.020 0.350 0.216 0.383 0.488
2000 -0.092 0.092 0.416 0.238 0.175 0.253 0.369
Table 3.1: Properties of re-weighted SIM model for randomly generated censoring
times, evaluated with 1000 Monte-Carlo simulations.





Censoring Rate Sample Size Bias (10−3) S.E. (10−2) ∆(10−1)
β1 β2 β3 β1 β1 β1
100 -7.610 1.631 -37.814 9.400 6.648 10.493 3.243
50% 500 0.550 7.485 -28.060 2.571 1.785 3.339 1.667
1000 2.244 6.336 -26.591 1.685 1.142 2.206 1.404
2000 2.724 6.210 -26.281 1.092 0.782 1.609 1.272
100 5.673 5.502 -18.270 4.831 3.231 5.694 2.109
30% 500 0.856 3.542 14.011 1.4381 1.010 1.938 1.192
1000 0.712 3.291 -12.064 0.877 0.604 1.183 0.984
2000 0.855 3.035 -11.305 0.556 0.400 0.883 0.858
100 -0.918 1.518 4.343 1.675 1.132 2.092 1.124
10% 500 0.082 0.773 -0.265 0.528 0.361 0.655 0.619
1000 0.108 0.642 2.213 0.3403 0.231 0.393 0.495
2000 0.090 0.526 1.793 0.2190 0.148 0.266 0.399
Table 3.2: Properties of re-weighted SIM model for covariate dependent censoring
times, evaluated with 1000 Monte-Carlo simulations.
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No Random Censoring Covariate Dependent Censoring
Models Sample Size Error SD Censoring 10% 30% 50% 10% 30% 50%
(n) (σ) PD SM Cox PD SM Cox PD SM Cox PD SM Cox PD SM Cox PD SM Cox PD SM Cox
50
0.1 916 920 942 906 883 947 857 802 940 772 677 940 910 882 947 869 811 946 789 714 943
0.2 878 878 902 877 867 899 828 774 899 755 703 899 879 860 906 838 798 902 765 697 891
A1: Group 1
100
0.1 946 949 953 930 922 949 887 844 943 837 746 943 922 901 949 923 864 953 865 781 946
A2: Group 2 0.2 899 905 909 886 880 904 869 817 902 802 719 902 890 864 910 893 838 914 851 770 900
200
0.1 950 950 951 934 922 948 920 869 951 890 810 952 940 927 951 929 883 948 917 816 951
0.2 905 904 909 897 891 909 889 836 906 865 797 909 909 897 908 895 856 904 873 797 908
50
0.1 899 884 594 846 838 602 785 760 619 739 709 603 865 842 603 810 770 610 737 701 606
0.2 836 834 587 822 814 599 778 767 604 711 684 585 838 820 586 785 760 602 724 694 590
A3: Group 1
100
0.1 902 895 605 899 887 629 856 835 623 792 776 621 895 888 619 888 846 623 825 749 626
A4: Group 2 0.2 856 861 597 865 856 629 825 809 608 770 737 612 860 861 619 852 826 613 791 738 620
200
0.1 922 917 657 893 891 646 892 863 631 850 823 638 913 914 661 892 864 631 860 808 643
0.2 893 889 654 857 852 641 843 825 622 835 796 630 885 879 651 870 853 625 837 790 639
50
0.1 854 855 534 823 807 563 769 749 600 682 654 556 818 797 561 776 755 578 651 635 561
0.2 817 814 530 797 793 558 743 715 567 662 650 557 804 797 575 743 725 562 649 614 541
A5: Group 1
100
0.1 874 874 565 834 832 582 804 786 576 782 738 580 864 853 563 811 783 556 759 716 557
A6: Group 2 0.2 845 843 553 802 793 586 785 755 579 739 707 574 842 832 568 803 780 568 732 682 548
200
0.1 904 903 566 862 863 567 844 821 608 818 771 593 867 864 588 852 826 601 812 784 600
0.2 862 868 580 839 850 564 825 804 600 792 755 580 843 845 575 819 799 601 800 763 595
50
0.1 798 784 532 757 743 537 673 664 547 539 550 529 736 725 533 603 606 526 505 478 527
0.2 756 751 547 727 726 537 630 633 540 568 568 534 751 738 528 581 591 507 490 463 531
A7: Group 1
100
0.1 843 838 557 844 836 554 759 743 545 627 604 542 824 821 521 741 725 556 588 564 525
A8: Group 2 0.2 799 798 550 820 815 564 751 728 546 599 591 542 808 808 525 710 689 549 570 548 536
200
0.1 892 885 564 877 864 549 835 796 563 754 712 540 872 858 526 820 804 528 658 628 547
0.2 866 867 578 839 835 548 804 778 553 716 687 540 832 829 544 782 781 539 650 634 539
Table 3.3: Frequencies of correct treatment assignments in 1000 test cases for three
methods: Probability of Dominance (PD), Smooth Means (SM), and Cox model
approach, in two groups case (K = 2) using linear and nonlinear regression models
that are listed in Table 3.6, under random and covariate dependent censoring.
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No Random Censoring Covariate Dependent Censoring
Groups Models Dimension Sample Size Error SD Censoring 10% 30% 50% 10% 30% 50%
(r) (n) (σ) PD SM PD SM PD SM PD SM PD SM PD SM PD SM
3
50
0.1 928 926 886 858 844 760 628 582 905 892 856 792 737 667
0.2 878 878 851 817 784 712 619 578 866 846 824 782 672 619
100
0.1 935 935 907 881 876 821 785 681 924 919 897 847 853 762
0.2 893 892 852 831 843 800 748 668 871 847 857 830 805 727
200
0.1 938 938 935 917 891 833 855 740 935 931 921 880 892 785




0.1 923 921 875 847 768 722 579 580 865 855 805 752 600 588
0.2 847 847 821 802 736 708 560 575 828 817 763 735 564 571
Three B2: Group 2
100
0.1 925 925 880 854 853 793 748 680 913 892 881 840 766 714
0.2 882 880 867 833 831 765 688 637 871 858 846 806 737 694
B3: Group 3
200
0.1 933 933 911 889 879 821 828 735 937 912 903 849 847 774
0.2 893 893 869 846 842 783 790 702 889 877 854 827 813 751
8
50
0.1 929 927 891 877 835 806 683 698 897 892 863 832 624 612
0.2 886 886 861 849 792 781 655 659 846 847 806 792 607 599
100
0.1 943 939 929 909 897 864 796 757 940 928 898 870 801 762
0.2 904 904 883 865 857 816 769 744 898 894 879 841 766 728
200
0.1 950 949 943 925 914 876 877 805 940 939 933 894 892 836
0.2 917 917 896 880 888 844 853 776 911 904 896 873 846 810
3
50
0.1 926 924 866 835 826 754 702 628 903 880 857 790 748 664
0.2 878 880 838 827 782 714 645 605 866 845 797 753 712 638
100
0.1 939 939 902 874 865 792 801 700 918 904 894 830 846 724
0.2 883 886 859 836 840 759 757 649 886 882 858 820 798 710
200
0.1 945 945 910 903 893 846 838 741 929 921 904 866 884 790
B1: Group 1 0.2 885 884 875 855 851 818 805 729 887 882 872 842 831 752
5
50
0.1 914 918 857 834 781 703 603 587 865 847 790 749 638 610
B2: Group 2 0.2 831 831 793 782 740 681 542 543 819 805 765 730 595 588
Four
100
0.1 922 922 892 873 862 797 748 664 911 889 871 815 779 705
B3: Group 3 0.2 874 875 842 823 792 729 717 674 857 842 818 775 744 680
200
0.1 938 937 911 886 882 832 845 741 924 908 907 866 872 790
B4: Group 4 0.2 872 872 848 835 838 798 786 736 862 852 847 811 821 751
8
50
0.1 887 887 837 820 744 725 585 603 857 853 732 717 580 591
0.2 833 834 791 766 714 692 542 568 798 789 709 700 548 560
100
0.1 918 917 871 855 830 799 690 693 914 909 847 801 719 716
0.2 874 875 834 828 773 746 702 671 860 852 788 759 708 685
200
0.1 928 929 908 895 877 827 823 751 915 900 896 871 829 775
0.2 890 889 869 853 830 793 782 710 877 863 849 803 785 751
Table 3.4: Frequencies of correct treatment assignments in 1000 test cases by two
methods: Probabilities of Dominances (PD) and Smooth Means (SM), in multiple
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Table 3.5: The used sets of parameters to generate censoring times for two groups
assignment cases.
Regression Functions
A1: 2.0 + 1√
3.19
(1.9X1 + 2X2 − 1.6X3)
A2: 1.8 + 1√
6.52
(4.8X1 − 3.5X2 + 2.7X3)
A3: 1.2+sin{ pi√
3.19
(0.7X1 + 1.2X2 − 1.1X3)}
A4: 1.2+cos{ pi√
6.62
(0.6X1 − 0.1X2 + 2.5X3)}
A5: 1.2+sin{ pi√
4.28
(X1 − 0.3X2 + 0.7X3 + 0.1X4 + 0.8X5 − 0.6X6 + 0.5X7 + 1.2X8)}
A6: 1.2+sin{pi + pi√
11.65
(2X1 +X2 + 0.5X3 + 0.5X4 − 0.7X5 + 0.1X6 + 2.3X7 − 0.6X8)}
A7: 1.2+cos{ pi√
1.26





(1.6X1 + 2.1X2 + 0.4X3)}+ 0.2X21
Table 3.6: Model functions that are used for two group treatment selection simula-











Table 3.7: Model functions that are used for multiple treatment selection simula-
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Table 3.8: The used sets of parameters to generate censoring times for multiple
groups (K > 2) assignment cases.
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PD SM
Arm-0 Arm-1 Arm-0 Arm-1
Arm-0 141 191 225 107
Arm-1 119 200 195 124
Total 260 391 420 231
Table 3.9: Two groups treatment assignment summary for ACTG-175 trial, by two
proposed techniques: Probability of Dominance (PD) and Smooth Means (SM).
Table 3.10: My caption
PD SM
Arm-0 Arm-1 Arm-2 Arm-3 Arm-0 Arm-1 Arm-2 Arm-3
Arm-0 6 62 137 127 114 82 69 67
Arm-1 7 64 138 110 104 94 63 58
Arm-2 12 61 136 115 117 65 64 78
Arm-3 17 67 152 125 133 87 53 88
Total 42 254 553 477 468 328 249 291
Table 3.11: Four groups treatment assignment summary for ACTG-175 clinical






























































































Figure 3.1: Graphs of log(∆)vs log(n) by re-weighted SIM model, for randomly
censored cases, with censoring percentages from left to the right: 50%, 30%, 10%.















































































Figure 3.2: Graphs of log(∆)vs log(n) by re-weighted SIM model, for covariate
dependent censored cases, with censoring percentages from left to the right: 50%,
30%, 10%. Dotted line represent the fitted liner line for the data.
54
CHAPTER 4
PERSONALIZED TREATMENT PLANS WITH MULTIVARIATE OUTCOME
MEASURES
4.1 Treatment Selection
In this section we describe the proposed procedure. Let (Y∗i ,X) be the
hypothetical (counterfactual) response vector and covariate pair for treatment i,
i = 1, . . . , K where without loss of generality larger values of the each component





′ are indicative of better
outcomes andX is a vector of r covariates. Assume further that a patient’s covariate
value X is used to obtain a lower dimensional composite patient score U(X). In
practice one cannot observe the whole composite vector (Y∗1, ...,Y
∗
K)
′ for a single
patient.
In the single response case (q = 1) using iid observations of type (Y˜1i,Xi, Ai),
i = 1, ..., n where Ai is the binary treatment indicator for two treatments and Y˜1i
is the observed single response for the ith patient, previous authors have proposed
the estimated difference in conditional means given a score U to compare two treat-
ments. For example, Zhang et al. (2012) use robust estimators of E[Y ∗11|A =
0, U(X)]− E[Y ∗12|A = 1, U(X)] where U(X) = X and A = 0, 1 assign treatments
1 and 2 respectively. For the K treatment case with a single outcome measure, one
may use the largest index corresponding to estimated values of




k = 1, ..., K for a suitable score function U as the best treatment. In contrast to this
approach, in the 1st project we consider pairs of independent observations (Y1k,Xk)
from the marginal distribution of (Y ∗1k,X), k = 1, ..., K for the treatment selection
for K treatments. In that work they proposed a method based on estimators of a
set of probabilities defined as
pk(u) = P [Y1k > maxk 6=jY1j|U(Xl) = u; l = 1, ..., K]; k = 1, ..., K (4.1)
and compared that method against the criteria that uses the largest index corre-
sponding to estimated values of
µk = E [Y1k|U(Xk) = u] (4.2)
k = 1, ..., K as the best treatment. Note that in (4.1) and (4.2), the Y s do not
denote the set of true counterfactuals for a patient (given the set of X) but are
independently distributed with the same marginal distributions (given the set of
X). Although the function pi(u) above does not use the joint distribution of
(Y ∗11, ..., Y
∗
1K ,X) for a patient with covariate value X, they argue that pi above
nevertheless gives a measure of dominance for the ith treatment over the others
and hence can be used in selecting the best treatment. This was suggested as an
alternative to measures based on conditional expectations (µk, k = 1, ..., K) which
require restrictive moment assumptions on the error distribution for inferential as-
pects in a regression context. The method based on the pis was very competitive
against methods based on µis for a variety of models as shown from their empirical
studies.
In dealing with multiple responses, we consider pairs of independent observa-
tions (Yk,Xk) from the marginal distribution of (Y
∗
k,X), k = 1, ..., K to select the
optimum treatment for K treatments using either vectors of smoothed conditional
means for each treatment or sets of probabilities defined in a similar fashion in (4.1)
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above. For example, in generalizing the approach of using the conditional means
for the response vector Yk = (Y1k, ..., Yqk)
′ we define
µik(ui) = E[Yik|Ui(Xk) = ui]; i = 1, ..., q; k = 1, ..., K (4.3)
and vectors µk(u) = (µ1k(u1), ..., µqk(uq))
′ for u = (u1, ..., uq)′ where components
of these vectors correspond to each response. Now we rank the K values for each
component to get size K vectors vi(u) = (vi1(u), ..., viK(u))
′ where vik(u) is the
rank of µik among µik, k = 1, ..., K for each i with the largest µik value given the
rank 1. Then, we use an aggregation method to combine these rank vectors to
get an overall ranking of treatments. In this work we use the method proposed in
Pihur et al. (2007, 2009) to aggregate these rank vectors for a given score vector
U0 = (U10, ..., Uq0)
′. In particular, for a suitably chosen set of weights ωi; i = 1, ..., q





over PK , the set of all permutations of {1, ..., K} to get a vector v∗ = (v∗1, ..., v∗K)′
where
v∗ = arg min
v∈PK
ψ(v).
Among possible distance measures for γ is the weighted Spearman’s Footrule dis-
tance (Pihur et al., 2007) which was used in our empirical work. We then define
the optimal treatment as
k∗(U0) = arg min
1≤k≤K
{v∗k} (4.5)
We illustrate the proposed procedure with a simple example. Suppose we

















For example, the first row of the second matrix above indicates that with respect
to the first response, the second treatment as the best followed by treatments 1 and
3. Now, if we use the aggregation algorithm in Pihur et al., (2007, 2009) which uses
both the values of µik, i = 1, ..., 4; k = 1, ..., 3 and their corresponding ranks in the
weighted Spearman’s Footrule distance γ combined with ωi = 1, i = 1, ..., 4 we get
the aggregated rank vector v∗ = (3, 2, 1)′ indicating that the treatment 3 is the best
among the three competitors. On the other hand, use of ω1 = 0.4, ω2 = 0.3, ω3 =
ω4 = 0.15, in the same aggregation algorithm results in v
∗ = (3, 1, 2)′ indicating
that treatment 2 is optimal. If we are to use conditional probabilities as in project-1
to rank the treatments, we consider
pik(ui) = P [Yik > maxk 6=jYij|Ui(Xl) = ui; l = 1, ..., K]; i = 1, ..., q; k = 1, ..., K
(4.6)
and use the same aggregation method above to vectors of ranks corresponding
to pk(u) = (p1k(u1), ..., pqk(uq))
′, k = 1, ..., K in a similar fashion. We base our
discussion on a set of Single Index Models relating the ith component Yik of the
response vector Yk for the kth treatment and covariates Xk via
Yik = gik (β
′
ikXk) + ik (4.7)
for i = 1, . . . , q and k = 1, ..., K where each βik is a r-vector of parameters, giks
are unknown link functions for which we assume some reasonable smoothness con-
ditions to hold, and ik are error terms with E[ik|X] = 0. Furthermore we assume
independence of iks across k = 1, ..., K for a fixed i where these terms are corre-
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lated across is for any given k. The Single Index formulation provides flexibility
and reasonable efficiency in modeling many types of data.
Our observations are of the following form. Let Yikj indicate the ith com-
ponent of the jth response from a group of nk individuals under treatment k with
associated covariate values Xkj, j = 1, . . . , nk. The sample sizes ni are assumed to
satisfy the condition that ni/N tends to a positive number where N =
∑
ni. Then,
for this data, relationship (4.7) is written as
Yikj = gik(β
′
ikXkj) + ikj, j = 1, . . . , nk. (4.8)
Following Siriwardhana et al. (2015) we define an appropriate overall score vector
U as follows. First define





Next, define the ith components of the combined overall score vectors as
Si (X) = max
k
{Sik}
δi (X) = arg max
k
{Sik} . (4.9)
Then, for a patient with covariate value X we define the patient score as U(X) =
(U1, ..., Uq)
′ where Ui = (Si, δi)′ for i = 1, ..., q. In practice one does not know the
error distributions and model functions for models defined in (4.7) and therefore
we cannot directly calculate either the µks or pks at a given score u. Thus, to
apply the proposed selection method, we first need to estimate components of these
vectors using a standard function estimation method. This requires observed Yikj
values as well as observed Ui, i = 1, ..., q values corresponding to those responses.
However, Us defined above are hypothetical scores for a covariate value X as we do
not know link functions giks and index vectors βiks. Hence, in estimating piks and
µiks, we propose to use “estimated” U(Xkj) values , Uˆ(Xkj), say, corresponding
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to responses Yikj, i = 1, ..., q; j = 1, ..., nk; k = 1, ..., K. Now, to obtain Uˆ(Xij)
values, suitable estimators of link functions giks and index vectors βiks can be
used to construct estimators Sˆi (X) and δˆi(X) of Si(X) and δi(X), respectively.
Estimators of the link functions and index vectors can be obtained using responses
for each i,i = 1, ..., q coupled with the corresponding covariate observations for any
given k, k = 1, ..., K, since this estimation amounts to estimating the mean function
of a vector random variable with covariates. There is a vast literature on estimating
the link function and the index vector of a single index model (see, for example,
Ichimura et al., 1993, Hristache et al., 2001, Yu and Ruppert, 2002 and references
therein) allowing us to use one out of a several available reasonable estimation
methods to estimate the gs and the βs. We used the procedure given in Ichimura
et al. (1993) in our simulations and data analysis in the sequel. In the sequel these
estimators will be generically denoted by gˆik and βˆik, respectively, for i = 1, . . . , q























Uˆi(x) = (Sˆi (x) , δˆi (x))
′ (4.10)
We randomly select an index δˆi in the unlikely event that multiple treatments
produce the same Sˆik.
Now, for a given i, i = 1, ..., q, we construct estimators for µik(u) and pik(u),
k = 1, ..., K at a given u = (s, d)′ as follows. For estimating µik for a given i
and k, we first let w be a kernel function with w ≥ 0 and ∫ w(t)dt = 1, and
let hl, l = 1, ..., K be a set of smoothing parameters. We define an estimator of



















δˆi (Xkj) = d
) (4.11)
where I(A) is the indicator of A. The estimator pˆik (u) of pik(u) for a given u is
obtained by 2.7.
For a realization x0 of the covariate X, if we knew the corresponding real-
izations of the scores, ui0 = (Si(x0), δi(x0))
′, we can estimate µik(ui0) and pik(ui0)
by µˆik(ui0) and pˆik(ui0) respectively. However, due to the aforementioned reasons,
we can only find an estimate uˆi0 of ui0 using (4.10) above. Thus, we use µˆik(uˆi0)
and pˆik(uˆi0) as our estimates of µik(ui0) and pik(ui0) respectively for i = 1, ..., q; k =
1, ..., K. The estimators µˆik(uˆ0), i = 1, ..., q; k = 1, ..., K and pˆik(uˆ0) are consistent
for µik(ui0) and pik(ui0) follows from arguments similar to those given in project-1.
Finally, for either using means or the probabilities, for a given estimated
score vector uˆ0 = (uˆ10, ..., uˆq0)
′, the estimated best treatment for a patient with





over PK and defining a
kˆ∗ = arg min
1≤k≤K
{vˆ∗k} (4.13)
where vˆ∗k, k = 1, ..., K are the ranks obtained by the minimization of the distance
function (4.12) for the corresponding procedure.
Bandwidth selection for estimating the link functions, piKs and µiks is a
challenging issue which has not been investigated in this work. However, meth-
ods suggested in Wand and Jones (1995) for kernel smoothing seemed to perform
reasonably well in our simulations and data analysis.
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4.2 Empirical Studies
In this section we present a simulation study that investigates the properties
of the proposed procedure in finite samples.
We conducted a series of simulations with the proposed procedure under
various settings. Primarily, we focused on the accuracy of treatment assignment
of a new (test) observation using estimated values of µik and pik functions from a
set of training data. This simulation study was performed for treatment groups
cases K = 2 and 3 with response dimension q = 2, 3 and 4. We selected our model
sets such that each model in a set dominates other competing models for some
combination of covariate values; in other words, none of considered models fully
dominate other models within the whole covariate space. This signifies, subjects
with distinct covariates vectors, could experience corresponding highest response
from different treatments illustrating the personalized medicine concept.
In our study, we first simulated K independent multivariate (dimension q)
samples of size n (n = 100 or n = 200) per group. The components of the r dimen-
sional covariate vectors X were generated from a r dimensional multivariate normal
distribution with zero mean and a covariance matrix with the ijth element equal to
ρ|i−j| where ρ was chosen from the set {0.1, 0.5, 0.9}. We examined r = 3, 8 and 10
cases. Using various link functions and index vectors, we obtained the treatment
responses from model (4.7) for each k. Here, for a given k, k = 1, ..., K, the errors
were generated from either a q dimensional multivariate normal distribution or a
multivariate t distribution with zero mean and a correlation matrix with the ijth
element given by x
|i−j|
i where xis were chosen from the set {0.1, 0.5, 0.9}. The R
package mvtnorm (Genz et al., 2015) was used for the generation of these random
vectors where in the multivariate normal case, the dispersion parameter σ was cho-
sen from the set {0.1, 0.3, 0.5} . The degrees of freedom for each marginal was set
at 3 and 8 for t variables. We examined the performance of the proposed method-
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ology under a variety of both linear and nonlinear regression models with the SIM
structure.
Once K samples were generated, we estimated the corresponding SIMs fol-
lowed by an estimation of scores at each covariate value. SIMs were estimated by
the procedure given in Ichimura et al. (1993) using Gaussian kernels. Then, a new
covariate value X0 was generated in the same manner as previous covariates above,
and for its corresponding estimated score uˆ0, we calculated µˆik(uˆi0) and pˆik(uˆi0) for
i = 1, ..., q; k = 1, ..., K and the corresponding kˆ∗ values for equal weights (ωi = 1
for all i) cases and few unequal weights cases. The kernel function in this estimation
was taken to be a U(−1, 1) probability density function. We chose all bandwidths
by the algorithm given by Wand and Jones (1995) for each i, i = 1, ..., K.






′ for k = 1, ..., K, corresponding to this
X0 using model (4.7) where the errors were generated independently from the same
error distribution that was used to generate the K original samples. Then we obtain
















′ and define the treatment assignment to be correct if
kˆ∗ = arg min
1≤k≤K
{ ˆˆv∗k}
for the kˆ∗ corresponding to the criteria using µˆiks or pˆiks.
We repeated this procedure 1000 times for each model and error distribution
combination. The frequency of correct treatment assignment for a representative set
of cases are given in the Tables 4.2 - 4.9. The results presented below are for model
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functions and index vectors given in Table 4.1 below and for covariate dimension
r = 10.
An examination of these tables reveal that the selection accuracy drops when
the error distribution has a high variability. Both methods, based on smoothed
means and the method based on pik have very comparable selection frequencies
in all cases. This pattern was seen even in the single dimensional response case.
The selection frequency appears to be slightly lower when the covariate correlation
is higher although the drop is very marginal in most cases. When the number
of responses was 4, selection frequencies appear to get lower as the correlation
among the responses increase. We also observed a slight increment in the selection
frequency when the number of responses are increased for all group sizes. This is
perhaps due to the performance of the rank aggregation method which seems to
perform better when aggregating a larger number of ranked lists compared with
just two lists.
4.3 ACTG-175 HIV Clinical Trial
In this section we illustrate our proposed method using a real clinical trial
dataset.
The data resulted from the ACTG 175 clinical trial (Hammer et al. 1996).
This trial was a randomized, double-blinded, placebo-controlled clinical trial that
was conducted for comparing antiviral medications for HIV-1 patients whose T-cell
CD4 counts were in the range of 200 to 500 per cubic millimeter. The dataset
(Juraska et al. 2012) contains information on 2136 HIV-1 infected individuals who
were randomized into four treatment arms; those treated with Zidovudine (arm-0),
combination of Zidovudine and Didanosine (arm-1), combination of Zidovudine and
Zalcitabine (arm-2), Didanosine (arm-3). Arms 0, 1, 2, and 3 contain 532, 519, 524,
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and 561 patients, respectively. T cell CD4 and CD8 are critical components in the
human immune system. Frequently, the severity of HIV progression is measured
through a decline in CD4 counts. This trial periodically measured both these cell
counts for each patient as the clinical outcome. In our analysis, we considered the
log transformed CD4 and CD8 counts of a patient after 20 weeks of treatment as
the bivariate clinical response. As covariates, we used log-CD4, log-CD8 counts at
baseline, age, weight, and the number of months a patient received the pre-antiviral
therapy.
We applied the proposed treatment assignment strategy to the data from
all four arms of the study. In each situation, we randomly selected 200 patients
from each arm as “training” data to estimate the SIMs. Remaining patients were
considered as new (test) patients. After fitting SIMs to training data we estimated
the scores for test cases and estimated the corresponding pik and µik functions at
those scores to assign each test patient to the best treatment group suggested by
the rank aggregation method.
Between CD4 and CD8 T cell types, the scientific literature on HIV/AIDS
often declare CD4 cell as the primary T cell type that is suppressing the HIV
cell replication, whereas the critical role of the CD8 cell is typically referred to as
the antibody reaction against cancers and various types of other viruses. However
some studies have illustrated the important role of the CD8 during early stages
of HIV progression (Eg: Streeck and Nixon, 2010). Therefore, when we applied
the proposed method with two responses (both CD4 and CD8), we weighted the
importance of two responses differently (ωCD4 = 0.6, ωCD8 = 0.4), by giving more
priority to the CD4.
We report the results for the joint response case (Table 4.10) and for cases
when CD4 and CD8 were considered as single responses (Tables 4.11-4.12). For
example, in Table 4.10, the (0, 0) cell indicates that only 6 out of 332 patients
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who were actually treated in arm-0 would have been assigned to arm 0 had we
used the proposed method based on pik’s. When we applied the new method based
on pik’s for the joint response, the majority: 773, out of 1336 test patients were
assigned to arm 1. Similarly, a great number: 668 were assigned to arm 1 using
the assignment based on µik’s. As shown in Tables 4.11 and 4.12, if we are to only
consider CD4 (or CD8) as the response, 828 (or 421) patients were assigned to arm
1 using pik’s, whereas 640 (or 400) individuals were correspondingly assigned to
arm 1 using the method given by µik’s. We observed a notable difference between
the number of individuals assigned to arm 0 using single responses. For instance,
if the CD4 was used as the response, only 14 individuals were assigned to arm 0
using pik’s. However, comparably more number of individuals: 367 were assigned to
arm 0 using the same approach, if the CD8 had been used. Comparing Tables 4.10
and 4.11, we noticed a clear agreement between the resulted overall assignment by
the weighted joint response and the single assignment by CD4, which is reasonable
since we used a larger weight for the CD4.
4.4 Discussion
In this project we proposed a novel personalized treatment plan to select the
optimal treatment from a set of multiple treatments when the outcome measures are
multivariate. This method is a single step procedure which can be easily applied.
The proposed method is based on semi parametric Single Index Models which add
great flexibility in modeling real life situations. Furthermore, this method can also
be used for quantile regression SIMs providing additional model flexibility compared
with existing methods based on conditional expectations. Our empirical studies
show that the proposed method performs very satisfactorily in selecting the optimal
treatment in a multiple treatment setting. Our analysis of a real clinical trials
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dataset which has the multiple treatment option reveals a possible changes if one
were to use multiple outcome measures as opposed to a single measure.
This project deals with complete responses. However, censoring is very com-
mon in practice. An extension of the proposed methodology to a covariate depen-




























































































































































ρe = 0.1 877 844 858 817 833 800
ρe = 0.5 901 863 878 852 829 816
ρe = 0.9 870 827 871 837 836 829
σ = 0.5
ρe = 0.1 678 680 648 650 678 682
ρe = 0.5 626 614 637 633 622 622
ρe = 0.9 630 634 629 623 569 569
n = 200
σ = 0.1
ρe = 0.1 919 862 892 862 913 867
ρe = 0.5 911 880 909 871 892 846
ρe = 0.9 914 860 911 866 900 859
σ = 0.5
ρe = 0.1 667 671 690 687 679 677
ρe = 0.5 626 632 634 636 676 670
ρe = 0.9 629 623 619 626 627 630




ρe = 0.1 626 626 643 630 603 610
ρe = 0.5 597 600 591 593 591 591
ρe = 0.9 549 550 541 542 508 499
DF = 8
ρe = 0.1 640 639 616 626 595 595
ρe = 0.5 566 564 600 595 590 581
ρe = 0.9 569 568 558 571 540 541
n = 200
DF = 3
ρe = 0.1 646 647 606 605 625 624
ρe = 0.5 600 604 580 582 589 596
ρe = 0.9 528 530 562 564 535 525
DF = 8
ρe = 0.1 640 640 640 649 627 631
ρe = 0.5 606 605 554 561 589 591
ρe = 0.9 553 556 549 555 538 537
Table 4.2: Frequencies of correct treatment assignments in 1000 test cases by the





























ρe = 0.1 864 860 842 841 792 781
ρe = 0.5 870 856 816 826 805 809
ρe = 0.9 885 875 826 815 799 792
σ = 0.5
ρe = 0.1 535 548 545 544 597 591
ρe = 0.5 558 538 521 528 535 524
ρe = 0.9 560 556 543 552 506 498
n = 200
σ = 0.1
ρe = 0.1 913 921 891 898 876 876
ρe = 0.5 897 899 878 871 873 870
ρe = 0.9 862 860 889 879 864 858
σ = 0.5
ρe = 0.1 587 581 572 581 579 559
ρe = 0.5 578 574 552 551 572 576
ρe = 0.9 576 556 531 535 536 538




ρe = 0.1 507 507 511 516 493 487
ρe = 0.5 496 496 526 506 511 519
ρe = 0.9 542 542 501 502 504 501
DF = 8
ρe = 0.1 516 516 491 491 524 527
ρe = 0.5 527 527 507 511 484 487
ρe = 0.9 513 513 523 510 505 516
n = 200
DF = 3
ρe = 0.1 506 506 525 534 498 499
ρe = 0.5 490 490 495 501 518 516
ρe = 0.9 499 499 526 517 532 524
DF = 8
ρe = 0.1 520 520 538 536 516 516
ρe = 0.5 510 510 523 521 538 532
ρe = 0.9 478 478 519 523 497 491
Table 4.3: Frequencies of correct treatment assignments in 1000 test cases by the





























ρe = 0.1 869 825 812 751 786 754
ρe = 0.5 855 795 806 757 811 779
ρe = 0.9 886 834 828 775 773 749
σ = 0.5
ρe = 0.1 617 613 640 640 573 576
ρe = 0.5 598 593 555 556 575 575
ρe = 0.9 557 555 541 538 521 519
n = 200
σ = 0.1
ρe = 0.1 870 824 863 832 853 811
ρe = 0.5 887 861 861 797 858 805
ρe = 0.9 875 807 874 819 851 789
σ = 0.5
ρe = 0.1 650 652 626 626 625 621
ρe = 0.5 610 609 569 576 602 607
ρe = 0.9 594 598 549 555 571 569




ρe = 0.1 575 566 559 547 555 560
ρe = 0.5 519 520 555 553 554 559
ρe = 0.9 541 528 532 537 518 518
DF = 8
ρe = 0.1 596 609 603 604 576 577
ρe = 0.5 572 577 562 565 544 551
ρe = 0.9 515 519 508 501 522 513
n = 200
DF = 3
ρe = 0.1 594 593 577 584 558 564
ρe = 0.5 577 571 545 545 551 547
ρe = 0.9 561 555 539 543 530 526
DF = 8
ρe = 0.1 611 615 581 594 607 612
ρe = 0.5 560 562 540 537 554 549
ρe = 0.9 509 505 532 533 503 514
Table 4.4: Frequencies of correct treatment assignments in 1000 test cases by the





























ρe = 0.1 622 577 587 563 559 547
ρe = 0.5 606 588 600 581 551 550
ρe = 0.9 629 580 596 563 584 558
σ = 0.5
ρe = 0.1 661 634 654 644 620 601
ρe = 0.5 650 614 658 632 630 625
ρe = 0.9 669 635 653 631 637 634
n = 200
σ = 0.1
ρe = 0.1 377 382 368 359 357 349
ρe = 0.5 372 394 370 368 379 391
ρe = 0.9 360 360 349 341 362 368
σ = 0.5
ρe = 0.1 379 389 372 355 367 370
ρe = 0.5 372 382 357 343 371 374
ρe = 0.9 359 368 347 353 360 358




ρe = 0.1 403 406 398 407 417 416
ρe = 0.5 403 404 395 390 403 409
ρe = 0.9 393 406 415 407 378 366
DF = 8
ρe = 0.1 422 426 442 447 448 430
ρe = 0.5 421 414 437 448 415 417
ρe = 0.9 414 421 421 419 421 429
n = 200
DF = 3
ρe = 0.1 367 375 384 382 355 356
ρe = 0.5 352 349 359 341 370 375
ρe = 0.9 365 362 367 363 326 311
DF = 8
ρe = 0.1 359 362 377 380 372 389
ρe = 0.5 376 386 363 366 372 375
ρe = 0.9 393 381 330 323 357 352
Table 4.5: Frequencies of correct treatment assignments in 1000 test cases by the





























ρe = 0.1 707 650 705 671 669 640
ρe = 0.5 720 671 682 652 672 635
ρe = 0.9 698 660 687 645 648 645
σ = 0.5
ρe = 0.1 380 400 368 369 385 407
ρe = 0.5 408 390 374 384 391 379
ρe = 0.9 401 408 382 384 386 386
n = 200
σ = 0.1
ρe = 0.1 806 753 790 718 729 690
ρe = 0.5 772 709 793 720 743 685
ρe = 0.9 783 737 800 725 738 704
σ = 0.5
ρe = 0.1 438 434 401 413 395 392
ρe = 0.5 385 391 393 399 396 395
ρe = 0.9 403 413 400 403 381 388




ρe = 0.1 350 327 370 362 369 360
ρe = 0.5 343 336 372 369 337 336
ρe = 0.9 339 343 339 328 349 348
DF = 8
ρe = 0.1 378 370 359 360 343 351
ρe = 0.5 336 333 343 345 338 341
ρe = 0.9 346 347 312 309 374 365
n = 200
DF = 3
ρe = 0.1 355 373 355 358 353 355
ρe = 0.5 357 363 345 353 337 335
ρe = 0.9 332 333 353 357 354 358
DF = 8
ρe = 0.1 382 385 339 341 373 373
ρe = 0.5 350 371 358 357 353 344
ρe = 0.9 343 338 368 373 354 344
Table 4.6: Frequencies of correct treatment assignments in 1000 test cases by the





























ρe = 0.1 741 682 685 637 648 643
ρe = 0.5 701 665 671 627 643 607
ρe = 0.9 709 640 703 649 636 610
σ = 0.5
ρe = 0.1 410 411 402 410 373 378
ρe = 0.5 375 385 382 376 384 378
ρe = 0.9 408 388 376 383 377 379
n = 200
σ = 0.1
ρe = 0.1 781 716 747 715 745 712
ρe = 0.5 737 684 722 690 684 659
ρe = 0.9 755 700 734 687 690 653
σ = 0.5
ρe = 0.1 438 425 437 439 408 416
ρe = 0.5 410 422 395 401 415 425
ρe = 0.9 419 413 394 393 410 397




ρe = 0.1 363 341 377 377 322 313
ρe = 0.5 339 351 337 333 354 352
ρe = 0.9 338 329 360 346 328 316
DF = 8
ρe = 0.1 341 351 320 316 346 336
ρe = 0.5 337 341 348 347 353 349
ρe = 0.9 352 342 319 320 363 368
n = 200
DF = 3
ρe = 0.1 365 352 377 379 328 320
ρe = 0.5 369 378 341 351 352 334
ρe = 0.9 357 359 335 317 354 352
DF = 8
ρe = 0.1 364 349 336 336 378 383
ρe = 0.5 368 375 351 355 340 345
ρe = 0.9 337 342 377 368 330 326
Table 4.7: Frequencies of correct treatment assignments in 1000 test cases by the





























ρe = 0.1 690 660 656 642 621 593
ρe = 0.5 699 658 652 627 612 606
ρe = 0.9 675 653 647 601 590 589
σ = 0.5
ρe = 0.1 397 414 368 374 401 401
ρe = 0.5 414 426 399 412 401 399
ρe = 0.9 407 419 374 391 376 369
n = 200
σ = 0.1
ρe = 0.1 734 702 731 688 677 664
ρe = 0.5 736 686 729 685 706 647
ρe = 0.9 742 709 728 681 704 685
σ = 0.5
ρe = 0.1 442 441 440 450 404 411
ρe = 0.5 398 391 387 396 408 411
ρe = 0.9 420 424 398 398 390 393




ρe = 0.1 368 353 336 336 363 357
ρe = 0.5 363 353 364 358 329 334
ρe = 0.9 330 342 362 353 338 335
DF = 8
ρe = 0.1 369 371 357 373 342 339
ρe = 0.5 362 368 349 350 353 362
ρe = 0.9 362 352 335 320 364 357
n = 200
DF = 3
ρe = 0.1 356 365 350 357 345 346
ρe = 0.5 370 374 378 377 341 349
ρe = 0.9 340 345 344 346 353 344
DF = 8
ρe = 0.1 366 372 362 363 380 364
ρe = 0.5 351 367 348 345 333 319
ρe = 0.9 354 353 364 364 358 358
Table 4.8: Frequencies of correct treatment assignments in 1000 test cases by the
proposed method, for three treatment groups with three responses, using weights,





























ρe = 0.1 701 678 690 655 634 611
ρe = 0.5 735 680 683 646 613 584
ρe = 0.9 704 667 665 624 608 597
σ = 0.5
ρe = 0.1 399 401 401 413 380 386
ρe = 0.5 372 371 391 386 377 371
ρe = 0.9 392 381 396 382 393 394
n = 200
σ = 0.1
ρe = 0.1 796 765 738 709 726 712
ρe = 0.5 771 737 748 710 697 670
ρe = 0.9 778 737 753 683 698 670
σ = 0.5
ρe = 0.1 404 407 430 439 412 417
ρe = 0.5 405 414 411 402 415 420
ρe = 0.9 400 409 394 384 396 388




ρe = 0.1 368 348 358 358 332 335
ρe = 0.5 324 342 333 337 344 326
ρe = 0.9 326 312 358 357 321 326
DF = 8
ρe = 0.1 355 352 325 340 366 358
ρe = 0.5 370 370 317 325 359 362
ρe = 0.9 339 334 337 324 355 354
n = 200
DF = 3
ρe = 0.1 368 367 349 359 344 339
ρe = 0.5 353 370 349 336 362 350
ρe = 0.9 365 354 349 326 343 339
DF = 8
ρe = 0.1 335 335 359 367 357 354
ρe = 0.5 360 374 365 373 363 360
ρe = 0.9 347 346 349 362 334 326
Table 4.9: Frequencies of correct treatment assignments in 1000 test cases by the
proposed method, for three treatment groups with four responses, using weights






















Arm-0 6 18 201 159 60 84 65 71
Arm-1 7 20 178 162 60 67 74 70
Arm-2 13 25 187 158 63 66 61 75
Arm-3 11 26 207 189 76 76 67 70
Total 37 89 773 668 259 293 267 286
Table 4.10: Treatment assignment summary for ACTG-175 clinical trial data, by
the proposed method selecting both CD4 and CD8 counts as clinical response using





















Arm-0 2 27 211 152 70 93 49 60
Arm-1 2 20 193 161 77 76 47 62
Arm-2 5 31 201 151 73 82 45 60
Arm-3 5 38 223 176 88 84 45 63
Total 14 116 828 640 308 335 186 245
Table 4.11: Treatment assignment summary for ACTG-175 clinical trial data, by






















Arm-0 89 89 125 93 59 42 59 108
Arm-1 76 85 94 96 75 42 74 96
Arm-2 98 78 94 106 73 33 58 107
Arm-3 104 97 108 105 68 37 81 122
Total 367 349 421 400 275 154 272 433
Table 4.12: Treatment assignment summary for ACTG-175 clinical trial data, by
selecting CD8 counts as the clinical response.
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CHAPTER 5
FLEXIBLE SEMI-PARAMETRIC REGRESSION OF STATE OCCUPATIONAL
PROBABILITIES IN A MULTISTATE MODEL WITH RIGHT-CENSORED
DATA
5.1 The Proposed Methodology
5.1.1 Data Structure and Notations
In this section we briefly describe the outline of a multistate model and
notations used. Suppose that starting from an initial state 0, a set of n individuals
move along an acyclic interconnected networked system of J number of states, 0, 1,
..., (J − 1) in a time continuous multistate model, where an individual enters the j
th state at most once. Such a model can be graphically represented as a directed
graph using arrows to represent transitions from one node to another. For example,
Figure 5.6 presents the progressive illness death model that contains three states.
Consider the i th, i = 1, ..., n, individual in the multistate system. Let Si(t)
be the state occupied by the individual at time t. Suppose, the time taken to reach
the final state (J−1) to be T ∗i , which can be subjected to right-censoring. Let Ci be
the right-censoring time and Ti = min{T ∗i , Ci} is the observed final transition time.
Define, δi = I(Ci ≥ T ∗i ) indicates observing the final transition. For any two states
j and j
′
, in case the ith individual moves from j to j
′
, we define Ui,jj′ to be the
transition time from j to j
′
, which is considered to be∞ if the transition is not made
at all. Let Ki(t) be the conditional survival function of the censoring distribution
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for the individual. Suppose Xi = (Xi1, Xi2, ..., Xip) is the individual’s p dimensional
covariate vector that contains subject specific baseline information. We assume full
data consists of independent and identically distributed copies of {S(t), X(t), δ(t)}
given by {Si(t), Xi(t), δi(t)}, corresponding to 1 ≤ i ≤ n, n individuals, which are
observed at points t in a contentious time frame (t ∈ [0,∞)). Our goal is to estimate
the conditional state occupational probabilities given baseline covariate vector (x):
pj(t) = Pr{S(t) = j|X = x}, j = 0, 1, ..., J − 1, based on the observed data.
5.1.2 Binary Choice Single Index Model for the Right-censored Data
Use of data weighting schemes for the purpose of bias reduction are well
known in statistical literature. One way to handle censored observation in the
context of regression is to introduce a re-weighing scheme to the original estimator
developed for complete data, in a way that the bias caused due to censoring fades
away asymptotically. This idea was first introduced by Koul, Susarla, and Van
Ryzin (1981) for the randomly right censored data in linear regression.
The main body of this work is based on the IPCW re-weighted Klein and
Spady (1993) binary choice single index model, which is used to estimate conditional
transitions and risk processes to formulate a conditional transition hazard matrix
given a covariate value at a specific time point. Generally speaking, conditional risk
processes estimated for a multistate model provide natural approximations for the
conditional state occupational probabilities. However such approximates could have
a noisy form in finite samples. Thus, we consider obtaining fairly stable estimates
using a product limit function of transitions hazards, which we will discuss in a
sequel.
Let Njj′ be the counting process for transitions from state j to j
′, with jumps
at t corresponding to ∆Njj′(t) =
∑n




and let Yj(t) =
∑n
i=1 I(Si(t−) = j) be the risk process of individuals occupying
state j just prior to t. These two process may not be completely observable due to
the right-censoring.
We assume the means of conditional at-risk process in jth state µYi,j(t|X)
and event process between states j to j′ µNi,jj′(t|X) of an individual i at t are in
following forms,
µYi,j(t|X) = E(Yi,j(t)|Xi) = ft,j(βTt,jXi), (5.1)
µNi,jj′(t|X) = E(Ni,jj′(t)|Xi) = ft,jj′(βTt,jj′Xi), (5.2)
where ft,j, ft,jj′ are unknown smooth functions and βt,j, βt,jj′ are p dimensional
unknown parameter vectors. Here we present IPCW modified versions of the Kevin
and Spardy (1993) binary choice single index model to estimate µYu,j(t|X = x) and
µNu,jj′(t|X = x), for a hypothetical individual (u) with a specified covariate vector
X = x. Since these functions are estimated in the same fashion, we describe the
proposed algorithm in terms of a generic subject specific process denoted by Hi(t).
Suppose we have the independent observations H1(t), H2(t), ..., Hn(t) from n
individuals on a right-censored stochastic process H(t) with corresponding censor-
ing indicators δ1(t), δ2(t), ..., δn(t) and respective survival probabilities of censoring
K1(t), K2(t), ..., Kn(t). Using the triplet Ωi(t) = {Hi(t), δi(t), Ki(t)}, i = 1, ..n, we
proceed to estimate E(H(t)|X = x) in the following manner. Suppose,
P (Hi(t) = 1|X = xi) = Pi(t) = Ft(β ′txi); i = 1, ..., n.






















s≥t[1 − λC(t|Z¯i(s))ds] and Z¯i(t) is a generalized covariate defined
for the ith individual, which we will explain in detail in the sequel, when estimating
Ki(t). Generally speaking Ki(t) does not have the survival function interpretation,
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unless Z¯i(t) is formed with non-time-varying covariates. We will later describe a
flexible model to estimate Ki(t).






















For the case of completely observed data, Klein and Spady (1993) introduced a semi-
parametric likelihood, by approximating Ft(β
′
xi) using a non parametric estimator,
which is similar to the leave-one-out estimator described by Ichimura, Hall, and















where φ(.) is kernel function with φ(.) ≥ 0 and ∫ φ(u)du = 1, and h is a smoothing
























where τˆi is a trimming sequence that is introduced by Klein and Spady (1993) for
feasible likelihood criterion, which down-weight observations for which the corre-
sponding densities are small. The solution of βt is the maximizer of the Lq(t). For
the finite sample problem, we obtain estimates (βˆt, h0) of βt, h by maximizing the
quasi log-likelihood function (Lq(t)) with respect to both βt and h simultaneously.
Finally, Ft(β
′














In the proposed method, we estimate conditional means of at-risk process
and event process between all possible pairs of nodes in the multistate model at t
given a covariate X = x, using the above procedure. Thus, we find µˆYj (t|X = x) and
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µˆNjj′(t|X = x) by fixing {Hi(t), Ki(t), δi(t)} by their respective processes given by
{Yi,j(t), Kˆi(t′−), δi(t′)} and {Ni,jj′(t), Kˆi(t′−), δi(t′)}, where t′ = min{t,minj′ 6=j{Ui,jj′}},
and δi(a) = I(Ci ≥ a).
Eˆ(Yj(t)|X = x) = nµˆYu,j(t|X = x)
Eˆ(Njj′(t)|X = x) = nµˆNu,jj′(t|X = x)
In the estimation process, one can conveniently choose elements of t as the
union of all event times of the multistate model. Since state-to-state conditional
transitions are supposed to be non-decreasing function of time, estimated means of
the conditional transitions are monotonized via isotonic regression with the gener-
alized pooled adjacent violators algorithm (Barlow et al., 1972; Leeuw, Hornik, and
Mair, 2009).
5.1.3 Conditional Transition Hazard Rates and State Occupation Probabilities
In an uncensored experiment, the conditional hazards of transitions from
state j to j
′
(j 6= j′) given a specific value of covariate vector X = x is given by,






, for some s ∈ [t, t+ dt)|S(t−) = j,X = x}/dt,
where S(t−) is the state occupied just before time t. Note that this conditional
transition hazard only condition on the current state for a given X = x. Hence this
also known as the partially conditional transition hazards (Pepe and Cai, 1993).
The cumulative (integrated) conditional state-to-state transition hazard ma-
trix (A(t|X = x)) for the multistate model can be obtained as,




αjj′ (u|x)du, if j 6= j ′
−∑j 6=j′ Ajj′ (t|X = x), otherwise.
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Now we obtain an estimator for Ajj′ (t|X = x) as described in Datta and Satten
(2002), which is given by,




dEˆ(Njj′ (u|X = x))/Eˆ(Yj(u|X = x)), if j 6= j ′
−∑j 6=j′ Aˆjj′ (t|X = x), otherwise.
Note that, components of the Aˆ(t|X = x) have the Nelson-Aalen form. Thus,
Aˆ(t|X = x) is referred as the generalized Nelson-Aalen estimator for a multistate
model. The process given by dEˆ(Njj′ (t|X = x)) can be obtained from the corre-
sponding jumps of estimated conditional state-to-state transitions between [t−, t).
In this calculation we interpret the division by zero to be zero. The estimator
of state occupation probabilities follows from the above results via the product
limit (integral). This estimator reduce to the Aalen-Johansen estimator (Aalen
and Johansen, 1978) under the independent censoring and it’s valid even when
the multistate model is not hold the Markovian property (Datta and Satten, 2001;
2002). The state conditional occupation probabilities on a given value of X = x,
pj(t|X = x) = Pr(S(t) = j|X = x), is given by,
pˆj(t|X = x) =
J−1∑
k=0
Yˆk(0 + |X = x)
n
pˆkj(0, t|X = x)
where pˆkj(0, t|X = x) is the (j, k)-th element of the matrix Pˆ (s, t|X = x) =∏
(s,t](I + dAˆ(u|X = x)).
5.1.4 Censoring Hazards and Estimation of the Weights Ki(t)
Let Zi(t) is a generalized covariate defined for individual i, 1 ≤ i ≤ n, at
time t, which may contains both baseline and additional covariates (could be time
varying) than the covariates of primary interest (X), that are affect the censoring
hazards. For example, current state occupation indicator at the given time t may
affect to the censoring hazard in addition to the baseline covariates. Suppose Z¯i(t) =
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σ{Zi(s) : 0 ≤ s < t} is the observed covariate history prior to t. We assume that
the censoring mechanism satisfies, λiC(Z¯i(t), Si(.)) = λ
i
C(t|Z¯i(t)), where λiC(t|.) =
limdt→0 Pr(Ci ∈ [t, t+ dt)|Ti ≥ t, .)/dt. We use the Aalen’s nonparametric additive
model (Aalen, 1980 and 1989) to calculate IPCW weights, which provides a flexible
structure to estimate the censoring hazards by allowing covariates to be varied over






where, Wi0(t) ≡ 1 and Wik(t) = fk(Z¯i(t)), k = 1, ...,m, are possibly time-dependent
function of the past history of the covariate process for subject i. βk(t) are unknown
regression functions that measure the effect of corresponding covariate function
on the censoring hazard. Define Wi(t) = (Wi1(t), ..,Wip(t)). Then the Aalen’s







I(Tj ≤ t)(1− δj)Wi(Tj)R−1(Tj)Wj(Tj),
where, R(t) =
∑n
i=1 I(Ti ≥ t)Wi(t)W
′
i (t). The estimated IPCW weight for ith





In this section we present a detailed simulation study that investigates the
properties of the proposed procedure in finite sample.
We conducted the simulation study using the progressive illness death model
given in Figure 5.6. In this model, an individual starting from the initial healthy
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state (state-0) at time 0, moves to the absorbing state (state-2) denoted as death, by
following either of two possible paths, where the path is controlled by an independent
Bernoulli random variable. An individual at state-0 has a 60% chance of moving
through the intermediate disease state (state-1) to the final state and 40% chance of
reaching the final state directly. We simulated n independent individuals starting
from state-0 at time 0, whereas n is chosen from the set {100, 500, 1000}. For each in-
dividual, we then generated a three dimensional covariate vector (X = (X1, X2, X3))
that contains subject specific information, where its first component (X1) is gen-
erated from the bernoulli distribution with the probability of 0.5 and the other
two components (X2, X3) are obtained from multivariate normal distribution with





We assumed that individuals’ transition times follow Log-Normal distributions,
in such a way that the log-mean parameters depend upon their baseline covari-
ate vectors. Likewise, transition times T01, T12, and T02 are drawn using log-
normal distribution (lnN(µjj′ , 0.5





X)2, and µ02 = (β
′
X)2 + 0.5 respectively. We chose β to be a normal-
ized vector given by β = (0.40, 0.79, 0.46)′. In the uncensored experiment, the time
(T ∗) required for an individual to move from state 0 to 2 directly or through the
intermediate state are T02 or T01 + T12, respectively. However, the observed time is
considered to be T = min{T ∗, C}, when the right-censoring is present. In this sim-
ulation study, we considered both random and covariate dependent right-censoring
cases with 25% and 50% censoring rates. The random censoring times are generated
from the Exponential distributions with scale parameters 3 × 10−2 and 1.5 × 10−1
for 25% and 50% cases, respectively. For the covariate dependent censoring setting,
we obtained censoring time using an Exponential distribution that is specified by
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an indicator function for a threshold value of a linear combination of covariates,
which is given by,
C ∼ I(β ′cX > w)exp(φ1) + I(β
′
cX ≤ w)exp(φ2).
We fixed w = 0.1 for βc = (0.3, 0.2, 0.5)
′ and select pairs (φ1, φ2) from the set of
{(6× 10−2, 1× 10−2), (1.8× 10−1, 9× 10−2)}, for respective 25% and 50% censoring
cases.
We applied the proposed procedure to estimate state occupation probabilities
for an arbitrarily selected covariate vector, that was given by x0 = (1.0, 0.2,−0.1).
In this work, we used uniform kernels for the IPCW re-weighted binary choice single
index models.
5.2.2 Absolute Error of Estimated State Occupation Probability
We examined the absolute error (∆L1(t|x0)), measured between estimated
and “true” state occupying probabilities at 25th, 50th, and 75th quantile points cor-
respond to state reaching (states - 1, 2) and leaving (state - 0) times, for the covariate
vector X = x0. ∆L1(t|x0) is defined as, ∆L1(t|x0) = E|θˆ(t|x0)−θ(t|x0)|, where θ(x0)
is the “true” conditional state occupation probability for X = x0 and θˆ(x0) is the
corresponding estimator by the proposed method. We approximated θ(x0) by the
proportions of state occupation using an uncensored experiment with large number
(10,000) of instances that are generated for the covariate vector X = x0. In this
study, we used Cox’s model (Cox, 1972) based alternative procedure as a benchmark
estimate, in which the state-to-state transitions hazards in the multi-state model
are estimated using Cox’s regression model fitted marginally for each transition,
where the corresponding baseline hazard function is estimated by Breslow’s method
(Breslow, 1972). Thus, the conditionally estimated transition hazards of transitions
between states j to j′ (j 6= j′; j, j′ = 0, 1, 2) at a given time t can be obtained as,
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0 (t) is the baseline hazard of transition from
state j to j′ at time t, γ = (γ1, γ2, γ3) is the three dimensional vector that contains
respective regression coefficients of baseline covariates X = (X1, X2, X3). Next, we
obtained the conditional transition hazards matrices based on αˆCoxjj′ (t|X) to derive
estimates for the state occupation probabilities pˆCoxj (t|X) at a specific covariate
value X = x0, by following the Aalen-Johansen formulation as discussed in Section
5.3.
We calculated ∆L1(t|x) via averaging 500 Monte-Carlo repetitions. Table
5.1 presents the resulted ∆L1(t|x) for selected settings under random and covariate
dependent censoring cases. Demonstrating reasonable performance, results for the
proposed method show a clear decline in the ∆NewL1 (t|x), as the sample size is in-
creased for all types of censoring and rates. As to be expected, ∆NewL1 (t|x) is higher
for scenarios with a larger censoring rate. ∆NewL1 (t|x) at 50th and 75th quantile times
are relatively larger than corresponding values at 25th quantiles.
Suppose ∆NewL1 (t|x) ∼ n−κ, and log{∆NewL1 (t|x)} ∼ −κlog(n). Complying with
this relationship, we observed a linear trend between log(n) and log{∆NewL1 (t|x)} in
every case. For example, Figure 5.6 shows linear relationships in plots of log(n) vs
log{∆NewL1 (t|x)} that are developed for the random censoring at a rate of 25%. This
infers that the proposed estimator is reaching the true conditional state occupying
probability, in an asymptomatic fashion. Clearly, throughout the whole experi-
ment ∆CoxL1 (t|x) remained almost unchanged with sample sizes. This result shows
considerably large L1 errors, especially at 50% and 75% quantile points for the
Cox approach compared to the proposed method, which suggests the Cox approach
is incapable of providing reliable state occupation probability estimates under the
selected transition model functions.
87
5.2.3 Coverage of Confidence Interval Developed for Estimated State Occupation
Probability
Next, we examined the empirical coverage probability of 95% bootstrap based
confidence bands developed for the estimated state occupation probability.
Let θˆh be the estimator of θ, which is calculated using a sample of size n
with a bandwidth (h) that results from a cross-validation process. Suppose θˆ∗ is the
respective bootstrap estimator which results from a bootstrap sample of size n that
obtained by re-sampling data with a replacement. Li and Datta (2001) described
the distributional relationship given by D(θˆh˜ − θ) ≈ D(θˆ∗ − θˆg˜), where θˆg is the
corresponding over-smoothed estimate that involves a larger smoothing parameter
g (g > h), satisfies limn→∞ hg = 0. Denote, υ
∗b = θˆ∗b−θˆg, b = 1, ..., B, where B is the









percentile points for the data given by υ∗1 , .., υ∗B . Thus,
(θˆh−θ) lies in the interval of [Qα/2, Q1−α/2] with a probability of (1−α), which yields
the (1 − α)% confidence interval for θ as [θˆh − Q1−α
2
, θˆh − Qα
2
]. Suppose θˆh˜ is the
conditional state occupation probability estimated by the proposed method using
a set of bandwidths h˜ = (h1, ., hm, ., hM), M ∈ Z+. The over-smoothed estimator
θˆg˜ can be determined as g˜ = (g1, ., gm, ., gM), such that gm > hm, 1 ≤ m ≤ M . For








In this simulation, we first calculated θˆh˜, θˆg˜ from a sample of n individuals. Then




1, .., B for B number of bootstrap samples. We chose ϕ to be 0.9 and B to be
100. For a randomly generated dataset, we determined the indicator of I
[
θ ∈
[θˆh˜−Q1−α2 , θˆh˜−Qα2 ]
]
, which shows the presence of empirically approximated “true”
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state occupation probability is inside the constructed confidence interval. Finally,
the coverage probability is determined by averaging indicators of 500 Monte-Carlo
repetitions. For simplicity, we focused on coverages at the 25th, 50th, and 75th
quantile time points corresponding to state reaching (states - 1, 2) and leaving
(state - 0) times, described earlier.
Due to the computational burden, this study was limited to random censoring
setting with sample sizes n = 100 and n = 500 cases. Resulted coverages that are
summarized in Table 5.2 show reasonable coverages close to the nominal level of 95%
almost in every case, which seemingly suggest that the proposed method potentially
holds a reliable precision.
5.2.4 Power and Size of Regression Parameters
In this section, we study the power and size properties of regression param-
eters in the IPCW re-weighted binary choice SIM model. For this purpose, we
focused on the parameters estimated for risk processes, which are natural approx-
imations for state occupation probabilities in a multi-state model. Following the
normality property of the binary choice SIM parameter estimates described by Klein
and Spady (1993), we evaluated the hypothesis represented by H0 : βp(t, s) = 0 vs
H1 : βp(t, s) 6= 0, p = 1, .., P , using the bootstrap method based standard error. For
illustrative purposes, this study is conducted for the 2nd component of β parameter
vector; β2, using the three state progressive illness death model with the transition
settings as described in section 3.1, but ranging the value of β2 in a sequence from
0 to 0.95, under the constraint that satisfies |β ′| = 1. This experiment is initiated
by estimating βˆ from a sample of n individuals at a fixed time. After that, we drew
n individuals from the original data with replacement to obtain the corresponding
bootstrap estimates: βˆ∗b , b = 1, .., B for B number of bootstrap samples. For each
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fixed value of β2 the corresponding estimate βˆ2 is tested for rejecting the above null
hypothesis. Likewise the power is computed by the average rejections in 500 Mote-
Carlo simulations, using 100 bootstrap per each. This power study is conducted
under random censoring settings with 25% rate for n = 100 and n = 500 cases.
We also compare our results with a method based on pseudo-values de-
scribed by Anderson and Klein (2007). In this approach, pseudo-values of the state
occupation probabilities are calculated using the Jackknife method which yields
pˆpsi (t) = n · pˆ(t) − (n − 1) · pˆ−i(t), i = 1, ..., n, where pˆ−i(t) is the Aalen-Johansen
(Aalen and Johansen, 1978) state occupation probability estimate obtained from a
sample of size n − 1 by eliminating the ith individual from the data, and pˆ(t) is
the corresponding estimate calculated using the whole sample. For the ith indi-
vidual, the most probable state occupation at a fixed time is determined using the
observed pseudo-values, which allows one to estimate the parametric Logistic regres-
sion model that relates state occupational indicators with the baseline covariates.
In such a way, we conducted the power study for the 2nd parametric component;
βps2 in the above Logistic model.
In Figures 5.6 and 5.6 we present powers and sizes evaluated at 25th, 50th,
and 75th quantile time points for a proposed model and pseudo-value approach,
respectively. Examining the properties of power functions derived for the IPCW
re-weighted binary choice SIM model, we observed a fair agreement between the
observed size with the nominal value of 0.05 for most scenarios that covered in the
experiment. Clearly, the power is steadily increased as the sample size increases
from n = 100 to n = 500. The overall behavior of power function provides key
evidence for the reliability of the new technique, showing its ability to detect crucial
covariates upon the state occupation at a given time. The pseudo-value technique
has illustrated poor performance in terms of the power, whereas the plots show
an irregular behavior in the power function, which can possibly be caused due to
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the incapability of handling subjects’ nonlinear transition mechanism with baseline
covariates by the logistic model that assumes a pre-specified linear model structure.
5.2.5 Robustness of the Proposed Method
The proposed method for estimating conditional state-to-state transitions
counts and at-risk processes is established on a strict condition that assumes the
underlying functions have the SIM form. However, in practice this may not often
hold. Thus, we performed a simulation study to investigate the performance of the
proposed method under perturbed SIM functions. Similar to Section 5.2, we exam-
ined the absolute error denoted by ∆L1(t) at quintile time points, using the same
three-state progressive illness-death model described in our previous simulations,
but using a new set of functions that have perturbed SIM structure. Likewise, in
this experiment, T01,T12, and T02 transition times are generated from Log-Normal
distribution (lnN(µjj′ , 0.5





2, and µ02 = (β
TX)2 + (ϑX2)
2 + 0.5 respectively, where X2
is the 2nd component in the covariate vector X = (X1, X2, X3). Consequently, this
new set of models violate the SIM conditions in temporal processes of multi-state
model.
In this study, we chose β and ϑ to be β = (0.40, 0.79, 0.46)′ and ϑ = 0.4. The
robustness of the proposed method was examined under the random censoring cases.
Table 5.3 summarizes both ∆NewL1 (t|x) and ∆CoxL1 (t|x) values that are obtained by
averaging 500 Monte-Carlo simulations. Similar to the outcome observed in section
3.2, ∆NewL1 (t|x) clearly declines with the sample size. Demonstrating the consistency
of our estimate, further investigation of the results show a linearity between log(n)
and log{∆NewL1 (t|x)} values (refer to Figure 5.6), that suggests the proposed method
is rather robust under perturbed SIM conditions. As we expected, the Cox approach
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demonstrated poor performance with the underlying simulation conditions. The
overall result has a high correspondence to the outcome we described in Section 5.2.
5.3 Applications
In this section, we illustrate two applications of the proposed method in real
data using bone marrow transplant study (Copelan et al., 1991), and spinal code
injury data (Harkema et al., 2012).
5.3.1 Bone Marrow Transplant study
The bone marrow transplant study had been conducted during years 1984 to
1989 for acute leukemia patients in four worldwide centers. This transplant surgery
is considered one of the standard therapies for acute leukemia condition. Usually,
a subject experiences various clinical conditions during the recovery process, after
receiving the transplant from a donor, which can be represented as states of a multi-
state model. In this study, 137 acute leukemia subjects underwent bone marrow
transplantation. After that, these individuals were followed up to a maximum of 7
years. In a multi-state representation, starting from the primary state of receiving
the bone marrow transplant, there are five intermediate states that an individual
may reach before he/she reaches the final (absorbing) state, which is relapse or death
by leukemia. Five intermediate states are represented by conditions of developing
Acute Graft Versus Host disease (GVHD); returning of platelet levels to normal
levels; returning of platelet levels to normal levels after developing acute GVHD;
Developing acute GVHD after platelet recovery; and developing chronic GVHD.
A schematic representation of the multi-state model is given in Figure 5.6. We
summarize the transition counts for the study in Table 5.4. For additional details
of this study and the dataset, we refer readers to Klein and Moeschberger (1997).
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The bone marrow transplant data described here has been analyzed by many
authors for various aspects. In this work, our primary goal is to estimate the
state occupation probability for a hypothetical individual represented by a specific
covariate vector. Among several covariates available, we use ages of patient and
donor for our work. We apply the proposed procedure by choosing the covariate
vector x = (28, 28)′ corresponding to patient’s age and donor’s age to estimate
the state occupation probability (pˆj(t|x), j = 0, .., 6). After that, we construct 95%
bootstrap method based confidence intervals by following the procedure described in
the simulation section. Datta and Satten (2001) showed that the censoring depends
on the currently occupied state. Hence we consider patient age and the time varying
covariate given by current state for calculating IPCW weights.
Figure 5.6 provides sets of plots that are show the estimated conditional state
occupation probabilities for an individual of age 28 who receives a bone marrow
transplant from a donor of the same age of 28. The plot of state-0 shows prob-
ability of staying at this state dramatically declines within a short period, which
means the individual possibly moves to another clinical state soon after he/she un-
dergoes surgery. As shown in the plot of state-2, the most probable second state for
such an individual must be the ‘Platelet Recovery’ state, whereas the probability
of staying in this state at the very beginning appears to be as high as 0.7. How-
ever, the state occupation probability for this state quickly decreases below 0.3 and
reaches an almost steady level within first 500 days of the surgery. Plots of states 1
and 3 clearly indicate that the chances of staying in ‘Acute GVHD’ and one of its
subsequent states given by ‘Platelet recovery after acute GVHD’ are very low for
the particular individual. As shown in the plot 4, occupying ‘Acute GVHD After
Platelet Recovery’ at the beginning seems to be close to 0.1, which then declines
gradually. The occupation probability at state-5 that is ’Chronic GVHD’, quickly
increases to approximately 0.25 and remains almost unchanged for a long span. As
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to be expected, the chance of moving to the absorbing state (Relapse/Death) in-
creases with time, then it reaches to a constant level after nearly 1000 days after the
surgery. Based on 95% bootstrap confidence intervals (with B = 500) developed for
state occupation probabilities, we observe reasonable precision with our estimates.
We provide another illustration (refer Figure 5.6) of conditional state oc-
cupation probabilities for two covariate vectors: x = (20, 20)′ and x = (40, 40)′.
Visual inspection of these plots shows some noticeable differences for two baseline
vectors. For example, the overall state occupation probability at ‘Platelet recovery
after acute GVHD’ state for an individual with x = (20, 20)′ is larger compared to
an individual with x = (40, 40)′. Conversely, occupying ‘Chronic GVHD’ state is
lower for x = (20, 20)′ than x = (40, 40)′ case. To determine if these differences are
statistically significant, we developed a test statistic and computed its correspond-
ing p-value using a re-sampling scheme. We calculated the mean absolute difference
D =
∫ |θˆ(t|X = x1)− θˆ(t|X = x2)|dEn(t), where θˆ(.|X = x) is the proposed estima-
tor of state occupation probability given X = x to quantify the overall difference for
above covariate vectors. We drew a bootstrap sample of size n by re-sampling labels
from the original data {1, .., n}, using simple random sampling. Then we re-sampled
X by drawing samples from the corresponding original data, which was performed
independently from the previous re-sampling step. After that we calculated D us-












In Table 5.5, we present the result based on B = 500 bootstrap samples. As shown
in the table, the difference at ‘Platelet Recovery After Acute GVHD’ is shown to
be significant at 5% significant level. Other differences, such as in ‘Acute GVHD
After Platelet Recovery’ can be considered as borderline significant.
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5.3.2 Spinal Cord Injury Study
Spinal code injury (SCI) data contains information on 296 subjects with in-
complete spinal code injury from a national activity-based rehabilitation program
(Harkema et al., 2012). The program primarily focused on individuals with clinically
incomplete SCI after discharge from inpatient rehabilitation. During the program,
patients underwent with sessions of locomotor training, based on a screening assess-
ment at enrollment. The locomotor training program is an activity-based therapy
for functions relating to standing and walking. Functional progress of these individ-
ual has been thoroughly evaluated periodically in terms of mobility, standing, and
stepping, after receiving therapeutic sessions. For instance, this study assessed 6-
minute walk and 10-meter walk tests. There are several clinical benchmarks defined
based on the walking speed of an individual. For example, 0.44 m/s represents the
minimum walking speed associated with the ability to walk in the community, 0.7
m/s separates those who require assistive walking devices from those who do not,
and 1.2 m/s approximately defines the speed required to cross a street at a stop-
light (van Hedel and Dietz, 2010). Thus, we represent the progress of a SCI subject
though the rehabilitation program as states of a multi-state model as follows: (1)
nonambulatory, (2) able to walk but slower than 0.44 m/s, (3) able to walk but
in between 0.44 to 0.7 m/s, (4) able to walk but in between 0.7 m/s to 1.2 m/s,
(5) able to walk faster than 1.2 m/s. A graphical representation of the multi-state
model with 5 states is given in Figure 5.9. We also provide a summary of transition
counts in Table 5.5. It is important to note that individuals in this study have been
entered to the multi-state model from various states, which is one of the primary
difference between SCI and bone marrow transplant studies. In a previous anlsysis
of this dataset, Lorenz and Datta (2015) estimated an individuals’ waiting time to
reach state-1 in the model, based on a linear hazards model approach.
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Among several subject specific measures given, we used (1) initial speed at
enrollment, (2) patient age at enrollment, (3) time from spinal cord injury to enroll-
ment, and (4) lower motor score from the International Standards for Neurological
Classification to estimate the state occupation probability for a given individual
with a specified baseline covariate vector. We noticed that SCI subjects with se-
vere conditions, such as nonambulatory or patients with slower walking speed than
0.44 m/s very rarely regain a walking ability than 1.2 m/s. Thus, most of these
patients have been subjected to right-censoring before they were discharged from
the program upon recovery, resulting approximately 82% censoring rate in terms of
reaching the final state. We believe the censoring hazards may have an effect by the
cumulative number of training sessions the individual received prior to censoring,
which can be considered as a time varying covariate. Thus, we use this informa-
tion in addition to baseline covariates to calculate the IPCW weights. Figure 5.6
presents conditional state occupation probabilities estimated using the proposed
method along with 95% bootstrap confidence intervals (B = 150), for an individual
with a covariate vector x = (0.08, 38.0, 0.92, 33.0)′, which corresponds to median
baseline covariates of study participants. For this individual, represent by the se-
lected covariate vector, the chance of occupying state-0 at the early period is close
to 0.5, which then sharply declines. There is an approximately 0.25 chance of oc-
cupying state-1 at the beginning, which relatively increases over time. Occupying
at states 2 gradually declines, while 3, and 4 considerably elevates when reaching
to 500 days of enrollment. We believe lack of transitions along with high rate of
censoring may have caused relatively large confidence bands for our estimates.
5.4 Discussion
In this work we proposed a novel method to estimate the conditional state
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occupational probability of a multi-state model, given a covariate, in the presence of
right-censoring. The proposed method has broad potential advantages in complex
multi-state problems, where the transition mechanism follows a dynamically varying
high nonlinearity with baseline covariates. We proposed IPCW re-weighted semi-
parametric binary choice SIM model to estimate state-to-state transitions and at-
risk processes, which allows one to estimate transition hazards between pairs of
states in the multi-state model. The integrated IPCW re-weighting scheme handles
the bias caused by censoring, ensuring theoretical properties of the model.
We present a series of simulation studies that investigates properties of the
proposed method in finite sample. We primarily focused on the L1 distance between
the estimated and true conditional state occupational probabilities (∆) given a vec-
tor of covariates, at a selected set of time points. Clearly, L1 distance seems to be
decreasing with the sample size for both random and covariate dependent censoring
mechanisms, under low and high censoring rates. These results suggest a linear
relationship between log(n) and log(∆). Thus, the proposed estimator seemingly
converges to the true conditional state occupation probability asymptomatically. A
study that investigates the coverage of bootstrap confidence intervals demonstrated
a reasonable agreement between the empirical coverage and the nominal level. We
also demonstrated the performance of the proposed model in examining the covari-
ate effects using a power study, whereas this study infers the poor performance
of pseudo-value based parametric method under complex transition mechanisms.
Although the proposed method is based on SIM conditions, evidence of our study
showed that the proposed estimator is rather robust under the model functions’
departure from SIM conditions, signifying the potential capability of the proposed
method for handling many real applications. Two applications of the proposed
method in real data were illustrated using bone marrow transplantation and SCI
data, which contain several possible clinical states.
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A possible extension for the current methodology could be generalizing for
high dimensional case that contain excessive number of covariates, which may be
achievable by imposing a strong dimension reduction criteria. Such an approach
may have wide range applications with sophisticated multi-state models under high
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100 6.673 8.463 6.605 8.342 6.629 8.277 6.921 8.049 7.472 8.211
500 3.610 8.503 3.378 8.608 3.549 8.491 3.710 8.249 3.884 7.947
1000 2.705 8.446 2.578 8.527 2.581 8.448 2.839 8.216 3.652 8.216
50%
100 7.719 18.358 7.399 18.355 8.120 18.360 7.927 18.210 8.158 17.916
500 4.569 18.210 4.317 18.681 4.397 18.459 4.543 17.990 4.898 18.105
1000 3.346 18.135 3.271 18.432 3.357 18.285 3.432 17.802 3.707 17.802
75%
100 7.189 26.345 8.032 26.281 8.154 26.236 7.631 26.001 7.670 25.447
500 4.312 25.956 4.441 26.751 4.720 26.397 4.156 25.567 4.485 25.896
1000 3.222 25.869 3.228 26.389 3.501 26.208 2.954 25.391 3.711 25.391
State-1
25%
100 5.202 5.153 5.521 5.441 5.872 5.377 5.464 5.149 5.902 4.903
500 2.966 4.970 2.867 5.113 2.871 5.064 2.798 4.936 3.087 5.139
1000 2.325 4.915 2.247 5.011 2.284 4.981 2.315 4.843 3.677 4.843
50%
100 6.560 11.149 6.246 11.446 6.332 11.505 6.866 11.269 7.477 11.025
500 4.189 11.048 3.776 11.235 3.601 11.165 3.580 11.070 4.144 11.262
1000 2.859 10.977 2.964 11.065 3.079 11.055 3.035 10.807 3.892 10.807
75%
100 7.484 14.094 7.508 14.637 8.115 14.661 7.934 14.455 8.279 13.916
500 4.369 14.055 4.448 14.272 5.042 14.146 4.420 13.920 5.108 14.375
1000 3.055 13.902 3.083 14.050 3.362 14.015 2.993 13.869 4.207 13.869
State-2
25%
100 7.206 7.584 6.398 7.566 6.792 7.310 7.136 7.131 8.475 6.853
500 3.902 7.186 3.506 7.519 3.718 7.392 3.883 6.954 4.209 7.321
1000 2.735 7.231 2.920 7.463 3.167 7.369 2.951 6.942 4.375 6.942
50%
100 7.871 15.720 9.151 16.071 8.930 15.756 8.907 15.074 10.095 15.081
500 4.777 15.636 4.245 16.217 4.743 16.062 4.698 15.305 5.509 15.165
1000 3.561 15.610 3.824 16.112 3.830 15.932 3.672 14.894 4.859 14.894
75%
100 7.229 22.660 7.317 23.761 8.286 23.327 7.611 22.088 8.091 22.218
500 4.587 23.096 4.326 24.026 4.896 23.722 4.621 22.565 6.082 22.022
1000 3.101 23.055 3.569 23.834 4.042 23.542 3.355 22.113 5.282 22.113
Table 5.1: L1 Distances of estimated state conditional occupying probabilities at
25th, 50th, and 75th quantiles of state reaching (states - 1, 2) and leaving (state -
0) times, with 500 Monte-Carlo simulations, for two different censoring mechanisms








25% 50% 75% 25%1 50% 75% 25% 50% 75%
No Censoring
100 0.93 0.94 0.97 0.91 0.95 0.98 0.95 0.97 0.98
500 0.91 0.93 0.94 0.91 0.93 0.94 0.94 0.92 0.93
Random Censoring
25% Rate
100 0.95 0.95 0.96 0.94 0.95 0.97 0.96 0.96 0.96
500 0.94 0.93 0.96 0.94 0.91 0.95 0.93 0.92 0.92
Random Censoring
50% Rate
100 0.93 0.96 0.97 0.91 0.95 0.97 0.95 0.96 0.99
500 0.98 0.97 0.97 0.98 0.96 0.95 0.97 0.96 0.91
Table 5.2: The coverage probability of 95% bootstrap based confidence intervals for
estimated state conditional occupation probabilities using the proposed method, at
25th, 50th, and 75th quantiles of state reaching (states - 1, 2) and leaving (state -
0) times, under random censoring with 0 to 50% rates, averaging 500 Monte-Carlo’s



























100 6.516 9.988 6.621 9.791 6.661 9.719
500 4.032 10.088 3.882 10.046 3.882 10.157
1000 3.050 10.043 3.082 10.018 3.086 10.102
50%
100 8.380 20.899 8.052 21.001 8.570 20.898
500 5.127 20.793 4.994 20.965 5.091 21.166
1000 3.932 20.754 4.045 20.806 4.274 20.932
75%
100 9.053 29.593 8.798 29.669 9.367 29.577
500 5.177 29.318 5.437 29.715 5.920 30.034
1000 4.065 29.288 4.032 29.505 4.427 29.709
State-1
25%
100 5.062 5.945 5.162 6.114 5.297 6.101
500 3.151 5.920 2.903 5.974 3.007 6.031
1000 2.356 5.872 2.415 5.938 2.507 5.984
50%
100 6.646 12.466 6.844 12.757 6.619 12.752
500 4.377 12.303 4.230 12.411 4.343 12.461
1000 3.311 12.253 3.362 12.303 3.469 12.353
75%
100 8.481 15.046 8.197 15.509 8.627 15.468
500 4.269 15.009 4.656 15.008 4.912 15.124
1000 3.382 14.859 3.285 14.894 3.587 14.945
State-2
25%
100 6.842 9.260 6.853 8.851 7.332 8.886
500 3.943 9.093 4.012 9.279 4.218 9.363
1000 2.974 9.138 3.052 9.206 3.359 9.289
50%
100 8.651 18.879 8.868 18.816 9.059 18.997
500 5.401 18.801 5.377 19.221 5.469 19.367
1000 4.096 18.842 4.251 19.054 4.626 19.193
75%
100 8.221 26.701 8.303 27.254 9.422 27.510
500 5.373 27.222 5.831 27.755 6.594 28.026
1000 3.902 27.212 4.323 27.575 5.133 27.836
Table 5.3: L1 Distances of estimated state conditional occupying probabilities at
25th, 50th, and 75th quantiles of state reaching (states - 1, 2) and leaving (state - 0)
times, with perturbed SIM models, under random censoring, based on averaging 500
Monte-Carlo simulations, using the proposed method and Cox-Regression approach.
100
To
From 0 1 2 3 4 5 6
0 0 7 117 0 0 1 12
1 0 0 3 0 2 2
2 20 0 19 44 34
3 0 0 1 2
4 2 11 6
5 32 27
6 83
Table 5.4: Matrix showing the state-to-state transition counts for the Bone Marrow
Transplant data
State D (10−2)
0: Bone Marrow Transplant 0.533 (0.65)
1: Acute GVHD 0.854 (0.15)
2: Platelet Recovery 3.457 (0.13)
3: Platelet Recovery After Acute GVHD 1.710 (0.03)
4: Acute GVHD After Platelet Recovery 2.152 (0.08)
5: Chronic GVHD 3.506 (0.15)
6: Relapse/Death 1.843 (0.42)
Table 5.5: Absolute mean difference between conditional state occupation proba-
bilities of two cases: x = (20, 20)′ and x = (40, 40)′, using the proposed method.
The corresponding p-values are in parenthesis.
101
To
From 0 1 2 3 4
0 79 47 10 0 0
1 68 38 16 0
2 39 33 7
3 55 27
4 32
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Figure 5.2: Plots of log(n) vs log(∆NewL1 (t|x)) generated at 25th, 50th, and 75th
quantiles of state reaching (states - 1, 2) and leaving (state - 0) times, under ran-
dom censoring with a rate of 50%. Dotted lines represent the corresponding liner









































































































































Figure 5.3: Plots showing power and size properties of β2 parameter in the re-
weighted binary choice SIM models, which are estimated for risk processes of the
three state progressive illness death model. Plots are generated at 25th, 50th, and
75th quantiles of state reaching (states - 1, 2) and leaving (state - 0) times, under









































































































































Figure 5.4: Plots showing power and size properties of β2 parameter in the pseudo-
value based Logistic regression models, which are estimated for state occupations in
the three state progressive illness death model. Plots are generated at 25th, 50th,
and 75th quantiles of state reaching (states - 1, 2) and leaving (state - 0) times,


































































































































































Figure 5.5: Plots of log(n) vs log(∆NewL1 (t|x)) generated at 25th, 50th, and 75th
quantiles of state reaching (states - 1, 2) and leaving (state - 0) times, under random
censoring with a rate of 50% with perturbed SIM models. Dotted lines represent







0: Bone Marrow  
    Transplant 
0: Bone Marrow  
    Transplant 
4: Acute GVHD After          
Platelet Recovery 
    Recovery 
2: Platelet 
    Recovery 
1: Acute GVHD 
5: Chronic GVHD 
3: Platelet Recovery 
    After Acute GVHD 
6: Relapse/Death 


































































































Figure 5.7: Plots of estimated conditional state occupational probabilities of 7 clin-
ical states in the bone marrow transplant data, by the proposed method for a co-
variate vector of x = (28, 28)′, along with 95% bootstrap based confidence intervals











































































































Figure 5.8: Plots of estimated conditional state occupational probabilities of 7 clin-
ical states in the bone marrow transplant data, by the proposed method for a two
covariate vectors: x = (20, 20) and x = (40, 40).
110
 State – 0 
Non-Ambulatory 
State – 1  
0 – 0.44 m/s 
State – 2 
0.44 – 0.7 m/s 
State – 3 
0.7 – 1.2 m/s 
State – 4  
> 1.2 m/s 
Figure 5.9: Graphical representation of spinal code injury multi-state model






















































































Figure 5.10: Plots of estimated conditional state occupational probabilities of 5
clinical states in the spinal Code Injury data, by the proposed method for a covariate
vector of x = (0.08, 38.0, 0.92, 33.0)′, along with 95% bootstrap based confidence
intervals (represented by the dotted lines).
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APPENDIX
In this Appendix we provide outlines of the proofs of the technical results of
project 1.
Proof. Proof of Lemma 1





f (εi) , (5.3)
where  = (1, . . . , K)
′, and ε = (ε1, . . . , εK)
′. For a K-vector a = (a1, . . . , aK)
′
and a subset I of {1, . . . , K}, let a(I) denote the (K − ‖I‖)- vector obtained from
a by removing the ith element from a for an i ∈ I, and, let a{I} denote the ‖I‖-
vector consisting of ai for i ∈ I. Without loss of generality, assume d = 1. Let
ti = (ti1, . . . , tiK)
′ be vectors in RK and tj (s) = (tj1 (s) , tj2 (s) , . . . , tjK (s))′ where
tij (s) =
 maxk>1 tik + s, if j = 1,tij, if j 6= 1 .










j=1 fT (tj (s)) dεdt1(1) . . . dtK(1)∫
. . .
∫ ∏K
j=1 fT (tj (s)) dt1(1) . . . dtK(1)
(5.4)
where  = (1, . . . , K)






ε ∈ RK |εi + tii (s) > maxk 6=1,i {εk + tkk (s)}
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ith
, . . . , 0
)









































































dt1(1) . . . dtK(1) (5.6)




′)− pi (u) = 0
proving the continuity of pi.
Now we show that p1 (u) > pk (u) for any k > 1. Since the denominator of
the right hand side of 5.5 is not affected by i, we only need to show the inequality for
the numerator. In the following discussion, we use the assumption that 1, . . . , K


















1 + t11 (s) ≥ max
j>1
{j + tjj (s)}
) K∏
j=1





1 + t11 (s) ≥ max
j>1




1 ≥ k + tkk (s)− t11 (s) and 1 ≥ max
j>1,j 6=k




k ≥ 1 + tkk (s)− t11 (s) and k ≥ max
j>1,j 6=k




k ≥ 1 + tk1 (s)− t1k (s) and k ≥ max
j>1,j 6=k

























































fT (tj (s)) dεdt1(1) . . . dtK(1)
Considering the assumption of f (0) > 0, it can be shown that the above inequality
is strict. This results in
p1 (u) > pk (u) .
Now we show an intermediate result that would be used in proving Theorem



























J∈J I [Yiji > maxk 6=i {Ykjk}] w˜J (s) η˜J (d)∑
J∈J w˜J (s) η˜J (d)
, (5.7)
The following lemma shows that p˜i above behaves almost as pi for any u in
large samples.
Lemma 2. Under Assumptions 1–4, for u = (s, d) such that f (s, d) > 0 for s in
an open interval containing s, we have p˜i (u)
P→ pi (u) if hi → 0 and Nhi → ∞,
i = 1, . . . , K.
The following lemmas are needed for the proof of Lemma 2.
Lemma 3. Let U and V be positive random variables, defined on a probability
space (Ω1,F1, P1), and A, B be a subsets of Ω1. We have (i) V ar (UIA) ≤
V ar (U) + E2 (U), (ii) |Cov (UIA, V IB)| ≤ |Cov (U, V )|+ E (U)E (V )
Proof.




≤ E (U2)− E2 (U) + E2 (U)− E2 (UIA)
= V ar (U) + E2 (U)− E2 (UIA)
≤ V ar (U) + E2 (U)
This proves (i).
Cov (UIA, V IB) = E (UV IAIB)− E (UIA)E (V IB)
≤ E (UV )− E (UIA)E (V IB)− E (U)E (V ) + E (U)E (V )
= Cov (U, V ) + E (U)E (V )− E (UIA)E (V IB)
≤ Cov (U, V ) + E (U)E (V ) ≤ |Cov (U, V )|+ E (U)E (V ) .
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Also,
Cov (UIA, V IB) = E (UV IAIB)− E (UIA)E (V IB) ≥ −E (UIA)E (V IB)








































I (d1 = d)
)2














It can be verified that
lim
h↘0




hσ2w,d0,k (h, s0) = fk (s0, d0)σ
2
w. (5.9)
Straight forward calculations yield the following result.
Lemma 4. For J, J ′ ∈ J , let A (J, J ′) = {1 ≤ k ≤ K : jk = j′k}, and B (J, J ′) =
{1, . . . , K} \ A (J, J ′). Then, for J, J ′ ∈ J , we have
E (w˜J (s) η˜J (d)) =
K∏
k=1
µw,d,k (hk, s) (5.10)
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Now we prove Lemma 2.














fk (s, d) +Op (max {hk}) . (5.12)
The proof of this result is a standard procedure for kernel estimation of smooth
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J,J ′∈J ,A(J,J ′) 6=∅
(|Cov (w˜J (s) , w˜J ′ (s))|+ E2 (w˜J (s))) (by Lemma 3)
≤
∑


































where c1 is a value that is not dependent on N . The right-hand side of Equation






(nk − 1)) terms. The number of terms for which
‖A (J, J ′)‖ = r is of order O (N rN2(K−r)). These terms are of the form c1 divided





































f (s, d) . (5.14)









f (s, d) . (5.15)
Combining 5.14 and 5.15 we have the desired result.
Remark 2. From the proof of Lemma 1 it can be seen that, to achieve optimal
rate of convergence for variances of both the numerator and denominator of the
right-hand side of 5.7, the bandwidth hk need to be of order N
−1/5 for k = 1, . . . , K.





















I (S (Xij) ≤ s, δ (Xij) = d) .
Furthermore, let y = (y1, . . . , yK)
′, s = (s1, . . . , sK)
′, d = (d1, . . . , dK)
′, F (n) (s,d) =
F
(n)
1 × . . .×F (n)K , F˜ (n) (s,d) = F˜ (n)1 × . . .× F˜ (n)K , and finally, let F = F ×F2× . . .×




∥∥∥F˜i − Fi∥∥∥∞ = op (N−1/2 log (N)).
Proof. Proof of Theorem 1










I (sd0 > maxk 6=d0 sk). By assumption 2, we
have that v (s) is Riemann-integrable. Let Si(j) denote the jth largest of S (Xi1) , . . . ,
S (Xini). Similarly we can define Sˆi(j). Since supx∈Sx





, we have, supx
∣∣∣S (x)− Sˆ (x)∣∣∣ = Op (N−2/5 logN). Addition-
ally, maxi,j
∣∣∣Sˆ (Xij)− S (Xij)∣∣∣ = Op (N−2/5 logN). After some tedious calculations
we can deduce that the above also implies maxi,j
∣∣∣Sˆi(j) − Si(j)∣∣∣ = Op (N−2/5 logN).
Combine this with 6, and the fact that dˆ0 → d0 (by the fact that s0 is positive and
the second part of Assumption 5), we can find sets AN ⊂ Ω and positive numbers
aN ∝ N−2/5 logN such that for ω ∈ AN , maxi,j
∣∣∣Sˆi(j) − Si(j)∣∣∣+∥∥∥F˜ (n) − F (n)∥∥∥∞ ≤ aN
and dˆ0 = d0. Define qij, i = 1, . . . , K; j = 1, . . . , ni to be values such that
F (qij, d) =
j
niF (∞,d)+1 . With condition 1, we can find bN ∝ N−1/2 logN such that
maxi,j
∣∣qij − Si(j)∣∣ ≤ bN if qij ∈ (s0 − d1, s0 + d1), a neighborhood of s0. Thus, by
properly redefining aN ∝ N−2/5, we can assume when ω ∈ AN , maxi,j
∣∣∣qij − Sˆi(j)∣∣∣ ≤






s outside (s0 − d1, s0 + d1). Let c1, . . . , cm be such that ci−ci−1 = 4bN , and the sup-











. Define c′i =
ci+ci+1
2
for i = 1, . . . ,m− 1.
For k = 0, . . . , 2K − 1, let Ik be collection of K-dimensional intervals of the form[
c∗i1 − c∗i1−1
]× . . .×[c∗iK − c∗iK−1], where c∗ij is either cij or c′ij depending the whether





be the supremum (infimum) of v (s) over s ∈ I. For J = (j1, . . . , jK) ∈ J ,
let I
(k)




































for k = 0, . . . , 2K − 1. Note that the first inequality in the above expression is







than d4bNni ‖f‖∞e. When ω ∈ AN , for J = (j1, . . . , jK) ∈ J , we have that























wˆJ (s) ηˆJ (d)
)
≤ 1






v¯IJ ,h − vIJ ,h
)]→ 0
Similarly, we can show that when ω ∈ AN ,
1
n1 . . . nK
(∑
J∈J
w˜J (s) η˜J (d)−
∑
J∈J
wˆJ (sˆ) ηˆJ (d)
)
→ 0
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